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Summary	of	the	article	111	 	112	 The	purpose	of	this	paper	was	to	discuss	meningitis	in	children	with	respect	to	113	 epidemiology,	how	the	introduction	of	vaccines	affected	the	incidence	of	bacterial	114	 meningitis.	It	then	focused	on	challenges	faced	by	clinicians	in	distinguishing	between	115	 bacterial	and	viral	meningitis.		116	 	117	 It	was	a	retrospective	study	which	started	with	a	review	of	89	articles	followed	by	a	118	 review	of	patient	folders	with	a	diagnosis	of	meningitis	during	the	study	period.	The	main	119	 question	was	whether	there	is	a	better	way	of	differentiating	between	bacterial	and	viral	120	 meningitis.	We	looked	at	different	methods	that	have	been	used	in	other	countries	and	121	 found	PCR	to	be	the	most	relevant	and	practical	one	for	our	population	especially	those	122	 children	who	get	antibiotics	before	lumbar	puncture	is	done.		123	 	124	 We	collaborated	with	the	department	of	virology	at	the	University	of	Cape	Town	which	125	 ran	PCRs	on	the	cerebrospinal	fluid	(CSF)	specimens	for	the	patients	whose	folders	were	126	 reviewed.	Clinical	and	laboratory	features	were	compared	between	different	groups	to	127	 see	whether	there	are	other	ways	of	telling	the	difference	between	VM	and	BM	in	128	 resource	poor	settings	where	PCR	is	not	available.	We	also	calculated	the	sensitivity	and	129	 specificity	of	PCR	compared	to	routine	microscopy	and	culture.		130	 	131	 We	concluded	that	PCR	is	a	better	test	for	patients	who	have	a	LP	after	administration	of	132	 antibiotics	however	it	should	be	used	in	conjunction	with	microscopy	and	culture	in	133	 order	to	get	the	bacterial	sensitivity	results	in	cases	of	bacterial	meningitis.	Financial	134	 evaluation	would	be	required	before	implementing	the	use	of	PCR	as	a	test	of	choice.		135	 	136	
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Chapter	1:		Introduction	and	Literature	review	137	
	138	
Abstract	139	
	140	
Introduction:	Viral	meningitis	(VM)	is	more	common	than	bacterial	meningitis	(BM)	and	141	 is	a	self-limiting	disease.	Clinicians	still	tend	to	admit	patients	with	VM	and	treat	them	for	142	 BM	 because	 they	 fear	 the	 morbidity	 and	 mortality	 that	 is	 associated	 with	 a	 delay	 in	143	 treating	or	not	treating	BM.	Unnecessary	admissions	have	huge	cost	implications	and	they	144	 separate	 children	 from	 their	 parents	 while	 exposing	 them	 to	 painful	 procedures	 and	145	 unnecessary	antibiotics.	146	 	147	
Methods:	 A	 structured	 literature	 review	 was	 undertaken	 to	 see	 whether	 clinical	148	 manifestation	and	examination	 findings	and	 laboratory	 findings	 including	viral	PCR	of	149	 cerebrospinal	 fluid	 can	 help	 to	 diagnose	 viral	 meningitis	 and	 avoid	 unnecessary	150	 admissions.	151	 	152	
Results:	Viral	and	bacterial	meningitis	have	similar	clinical	findings.	CSF	examination	is	153	 crucial	in	confirming	the	diagnosis	of	meningitis.	Microscopy	and	culture	remain	the	gold	154	 standard	in	making	the	diagnosis.	The	introduction	of	the	Haemophilus	influenzae	type	b	155	 and	 pneumococcal	 vaccines	 into	 the	 South	 African	 Expanded	 Programme	 on	156	 immunization	(EPI)	markedly	reduced	the	incidence	of	invasive	Haemophilus	influenzae	157	
type	b	and	pneumococcal	disease	in	children	under	5	years-of-age	as	in	other	countries	158	 where	 they	 are	 used.	 Viral	 meningitis	 is	 the	 leading	 cause	 of	 childhood	 meningitis	159	 however	the	clinical	and	CSF	findings	in	viral	meningitis	and	bacterial	meningitis	overlap.	160	 The	 sensitivity	 of	 CSF	 culture	 has	 been	 shown	 to	 be	 around	 81.3%,	 but	 is	 very	much	161	 affected	by	prior	antibiotics.	Traumatic/bloody	CSF	taps	also	make	it	difficult	to	interpret	162	
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results.	 Inflammatory	 markers	 have	 been	 used	 in	 conjunction	 with	 CSF	 results	 in	163	 differentiating	 between	 BM	 and	 VM	 however,	 the	 use	 of	 polymerase	 chain	 reaction	164	 technique	in	the	diagnostic	methodology	improves	the	sensitivity	to	more	than	95%.			165	
	166	
Conclusion:	Viral	meningitis	is	common	worldwide.	Real-time	multiplex	PCR	offers	value	167	 in	 accurately	 detecting	 common	 viral	 and	 bacterial	 pathogens	 thus	 allowing	 for	168	 appropriate	patient	management.	In	order	to	avoid	the	risk	of	not	identifying	organisms	169	 not	included	in	the	PCR	assay	and	further	not	being	able	to	do	susceptibility	testing	on	170	 those	organisms,	it	important	to	realize	that	PCR	testing	would	have	to	be	done	in	addition	171	 to	culture,	and	not	as	a	replacement.			172	
	173	
Aims	and	objectives	of	the	research	project	174	
	175	
	176	
• To	determine	the	proportion	of	meningitis	due	to	common	viral	pathogens	177	 in	children	over	two	months	of	age	using	PCR	testing.	178	
• To	determine	the	number	of	cases	of	meningitis	due	to	common	viral	and	179	 bacterial	causes	in	children	admitted	to	the	Red	Cross	War	Memorial	180	 Children’s	Hospital	(RCWMCH),	Cape	Town.		181	 • Viruses	tested	for	were:	enteroviruses,	herpes	simplex	virus	and	182	
mumps	virus.	183	 • Bacteria	tested	for	were:			Neisseria	meningitidis,	Haemophilus	184	
influenzae	type	b	and	Streptococcus	pneumoniae.		185	
• To	correlate	the	clinical	diagnosis	of	meningitis	with	laboratory	findings	186	 of	viral	meningitis.	187	
• To	determine	the	association	of	abnormal	cerebrospinal	fluid	188	
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(CSF)	findings	and	confirmed	diagnosis	of	HIV	infection.	189	
• To	describe	the	proportion	of	viral-PCR	positive	and	negative	190	 patients	treated	as	bacterial	meningitis.	191	
	192	
1.2	 Aims	and	objectives	of	literature	review	193	 	194	 Our	review	of	the	literature	was	focused	on	meningitis	in	children	over	the	age	of	two	195	 months	with	respect	to	the	following:	196	
• The	epidemiology	of	meningitis	in	South	Africa.		197	
• Correlation	between	clinical	diagnosis	of	meningitis	with	laboratory	findings	of	198	 viral	meningitis.		199	
• Diagnostic	 challenges	 resulting	 from	 bloody	 CSF	 tap	 and	 prior	 exposure	 to	200	 antibiotics.	201	
• The	value	of	laboratory	markers	of	sepsis	in	making	the	diagnosis	of	meningitis.	202	
	203	
Methodology	of	the	literature	review	204	
	205	 A	structured	literature	review	was	done	on	PUBMED	(www.ncbi.nlm.nih.gov)	using	206	 both	text	and	MeSH	terms.	In	addition,	textbooks	and	articles	identified	in	reference	207	 lists	of	individual	papers	were	selected	if	considered	appropriate.	An	independent	208	 literature	search	was	also	conducted	using	Google	Scholar.	The	following	terms	and	209	 search	filters	were	used.		210	 	211	 Our	search	inclusion	criteria	included	human	studies	reported	in	English	and	age	212	 limitations	were	customized	for	children	aged	0-months	–	18-years.	We	initially	213	 looked	only	at	articles	published	between	2003	and	2013,	which	is	10	years	prior	to	214	
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the	current	study	but	for	the	epidemiology	analysis,	we	did	not	apply	any	215	 restrictions	as	we	wanted	to	look	at	the	prevalence	of	meningitis	before	and	after	the	216	 introduction	of	Haemophilus	influenzae	type	b	(Hib)	conjugate	vaccine	into	the	217	 Expanded	Programme	on	Immunisation	(1999),	and	the	7-valent	pneumococcal	218	 conjugate	vaccine	(PCV)	in	April	2009	and	13-valent	PCV	in	April	2011.	219	 References	that	focused	on	meningitis	caused	by	pathogens	other	than	our	tested	220	 pathogens,	and	mycobacterium	tuberculosis	(TB)	were	excluded.	221	
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Table	1:	Results	of	the	literature	review	222	
	223	
Search	terms	 MeSH	Term	 Results	
Viral	meningitis	in	
Children	
("virology"[MeSH	Terms]	OR	"virology"[All	Fields]	OR	"viral"[All	Fields])	AND	"meningitis	in	children"[All	Fields]	AND	(("2003/01/01"[PDAT]	:	"2013/12/31"[PDAT])	AND	"humans"[MeSH	Terms]	AND	("infant"[MeSH	Terms]	OR	"child"[MeSH	Terms]	OR	"adolescent"[MeSH	Terms]))	
122	overall,	45	in	
	
past	10	years	
viral	meningitis	AND	
prevalence	
("meningitis,	viral"[MeSH	Terms]	OR	("meningitis"[All	Fields]	AND	"viral"[All	Fields])	OR	"viral	meningitis"[All	Fields]	OR	("viral"[All	Fields]	AND	"meningitis"[All	Fields]))	AND	("epidemiology"[Subheading]	OR	"epidemiology"[All	Fields]	OR	"prevalence"[All	Fields]	OR	"prevalence"[MeSH	Terms])	AND	(("2003/01/01"[PDAT]	:	"2013/12/31"[PDAT])	AND	"humans"[MeSH	Terms]	AND	English[lang]	AND	("infant"[MeSH	Terms]	OR	"child"[MeSH	Terms]	OR	"adolescent"[MeSH	Terms	
240	
Viral	meningitis	in	
Children	AND	South	
Africa	
("virology"[MeSH	Terms]	OR	"virology"[All	Fields]	OR	"viral"[All	Fields])	AND	"meningitis	in	children"[All	Fields]	AND	("South	Africa"[MeSH	Terms]	OR	("south"[All	Fields]	AND	"africa"[All	Fields])	OR	"south	africa"[All	Fields])	
5	articles-	2	deemed	
relevant	
Viral	meningitis	AND	
PCR	
(("meningitis"[MeSH	Terms]	OR	"meningitis"[All	Fields])	AND	("diagnosis"[Subheading]	OR	"diagnosis"[All	Fields]	OR	"diagnosis"[MeSH	Terms]))	AND	PCR[All	Fields]	AND	(("2003/01/01"[PDAT]	:	"2013/12/31"[PDAT])	AND	"humans"[MeSH	Terms]	AND	English[lang]	AND	jsubsetaim[text]	AND	("infant"[MeSH	Terms]	OR	"child"[MeSH	Terms]	OR	"adolescent"[MeSH	Terms]))	
125	
Meningitis	AND	HIV	 ("meningitis"[MeSH	Terms]	OR	"meningitis"[All	Fields])	AND	("HIV"[MeSH	Terms]	OR	"hiv"[All	Fields])	AND	(("2003/01/01"[PDAT]	:	"2013/12/31"[PDAT])	AND	"humans"[MeSH	Terms]	AND	English[lang]	AND	("infant"[MeSH	Terms]	OR	"child"[MeSH	Terms]	OR	"adolescent"[MeSH	Terms]))	
248	
Meningitis	and	CRP	 (("meningitis"[MeSH	Terms]	OR	"meningitis"[All	Fields])	AND	CRP[All	Fields])	AND	("humans"[MeSH	Terms]	AND	English[lang]	AND	jsubsetaim[text]	AND	("infant"[MeSH	Terms]	OR	"child"[MeSH	Terms]	OR	"adolescent"[MeSH	Terms]))	
39	
224	
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Literature	review	findings	225	
	226	 	227	 The	search	yielded	779	articles	as	presented	in	Table	1.	After	scanning	abstracts	and	228	 topics	a	total	of	699	were	deemed	relevant	but	only	89	were	suitable	for	our	review.	229	 The	South	African	articles	identified	which	mirrored	the	aim	of	our	research	project	230	 were	 old.	 The	 latest	 South	 African	 articles	 found	 focused	 mainly	 on	 tuberculous	231	 meningitis	(TBM).		232	 	233	
Introduction	234	
	235	 Infectious	diseases	have	contributed	to	most	of	the	under-five	deaths	in	developing	236	 countries	and	this	led	to	the	introduction	of	antibiotics	to	treat	patients.	Since	the	237	 1940s	antibiotics	have	decreased	morbidity	and	mortality	due	to	infectious	diseases	238	 but	the	problem	we	have	now	is	the	unnecessary	use	of	them	which	has	contributed	239	 to	antibiotic	resistance	(1,	2).	According	to	the	Medical	Research	Council	(MRC)	240	 report	from	the	year	2000	bacterial	meningitis	was	found	to	be	the		10th	most	241	 common	cause	of	under-	five	mortality	in	South	Africa(3).	242	 	243	 It	is	a	serious	life-threatening	illness	responsible	for	an	estimated	200	000	deaths	of	244	 children	outside	the	neonatal	period	each	year	(4).	Early	initiation	of	antibiotics	has	245	 been	shown	to	decrease	morbidity	and	mortality	from	meningitis.	246	 	247	 The	South	African	Group	for	Enteric	Respiratory	and	Meningeal	disease	Surveillance	248	 (GERMS-SA)	for	the	year	2016	confirmed	that	the	introduction	of	the	Hib	conjugate	249	
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vaccine	into	the	Expanded	Programme	on	Immunisation	(EPI)	for	South	Africa	in	1999	250	 resulted	in	a	reduction	of	Haemophilus	influenzae	(Hib)	cases.	The	report	indicated	that	251	 most	cases	of	invasive	Hib	in	2016	occurred	in	children	<15years-old	who	were	252	 unvaccinated,	the	main	affected	group	were	infants.	The	same	report	also	established	253	 that	the	introduction	of	7-valent	pneumococcal	conjugate	vaccine	(PCV)	in	April	2009	254	 and	13-valent	PCV	in	April	2011	also	resulted	in	a	substantial	reduction	in	the	255	 incidence	of	pneumococcal	meningitis	in	children	<5	years	of	age	from76%	to	58%;	256	 prematurity	and	HIV	disease	considered	important	risk	factors	(5).	von	Gottberg	et.al	257	 reported	a	65%	decrease	in	number	of	Hib	cases	in	children	under	the	age	of	one	258	 (from	55	cases	in	1999–2000	to	19	cases	in	2003–04).	This	shows	a	decrease	in	Hib	259	 disease	burden	among	South	African	children	following	conjugate	vaccine	introduction	260	 (6).		261	 		262	 	263	 Although	there	is	no	current	vaccine	for	Neisseria	meningitidis	in	our	current	South	264	 African	EPI,	GERMS-SA	2016	report	also	revealed	that	a	total	of	131	cases	of	265	 laboratory-confirmed	meningococcal	disease	were	identified	by	the	surveillance	266	 system.	Compared	to	the	2015	report,	the	incidence	of	meningococcal	meningitis	was	267	 slightly	lower	(0.23	vs	0.28	cases	per	100	000	population).	According	to	the	report,	it	268	 is	unclear	whether	these	changes	are	a	true	reflection	of	changes	in	the	incidence.	It	269	 could	also	be	due	to	changes	in	the	ability	to	confirm	disease	in	the	laboratory	or	270	 changes	in	reporting	to	the	surveillance	network	(1,	5).		In	Latin	America,	Argentina	271	 and	the	Middle	East;	countries		which	have	similar	immunisation	schedules	to	ours	272	 have	confirmed	that	VM	is	the	most	common	cause	of	meningitis	outside	the	neonatal	273	 period	with	enterovirus	being	the	most	common	identified	pathogen	(7,	8).	274	
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	275	 VM	remains	an	important	cause	of	morbidity	and	financial	burden	and	merits	efforts	276	 to	improve	diagnostic,	treatment,	and	prevention	options	(9).	Financial	burden	comes	277	 mainly	from	incorrect	diagnosis,	patient	admission	and	administration	of	antibiotics	278	 because	of	fear	of	missing	bacterial	meningitis.	279	 	280	 Bacterial	meningitis	(BM)	on	the	other	hand	is	a	severe	infection	and	can	rapidly	281	 progress	to	multi-organ	failure	and	death.	Numerous	sequelae	include	seizure	282	 disorders,	focal	neurologic	deficits,	hearing/vision	loss,	and	impaired	cognitive	283	 functioning.	Approximately	25%	of	survivors	in	the	United	States	have	moderate	or	284	 severe	sequelae	(10).			285	 	286	 The	other	problem	with	our	current	laboratory	methods	is	that	they	are	inadequate.	287	 Administration	of	antibiotics	before	collecting	the	cerebrospinal	fluid	(CSF)	can	results	288	 in	negative	culture	results	even	in	the	presence	of	bacterial	meningitis	(11).	Secondly,	289	 the	turnaround	time	for	both	microscopy	and	culture,	including	Gram	stain,	is	affected	290	 by	whether	the	on-site	laboratory	is	able	to	provide	this	service	and	culture	may	take	291	 up	to	48hours	to	provide	definitive	identification	and	sensitivity	results.		292	 	293	 BM	usually	presents	with	a	polymorph	predominance	in	the	CSF	with	a	high	protein	294	 and	 low	 glucose,	 sometimes	 positive	 microscopy	 and	 culture	 results	 whereas	 VM	295	 would	 have	 lymphocytes	 predominance	 and	 normal	 chemistry.	 Studies	 have	 also	296	 shown	 that	 early	 viral	 meningitis	 can	 also	 present	 with	 a	 predominance	 of	297	 polymorphs(12).		298	 	299	
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Another	 huge	 diagnostic	 problem	 is	 that	 of	 differentiating	 between	 TBM	 and	 viral	300	 meningitis	because	they	both	have	 lymphocyte	predominance	 in	 the	CSF(12).	While	301	 viral	meningitis	and	TBM	do	share	a	lymphocyte	pleocytosis,	the	CSF	protein	levels	are	302	 usually	markedly	different;	GeneXpert	on	CSF	also	offers	some	option	to	differentiate	303	 TBM	from	viral	meningitis.	304	 	305	 Swingler	 et	 al.	 did	 a	 retrospective	 review	 of	 children	who	were	 presumed	 to	 have	306	 bacterial	meningitis,	and	found	antibiotic	treatment	to	be	unjustified	in	35	(81.4%)	of	307	 the	43	patients	treated	for	longer	than	2	days	(13).	The	issue	with	inappropriate	use	of	308	 antibiotics	is	that	it	may	enhance	resistance	or	cause	adverse	effects.	Inappropriately	309	 admitting	children	can	also	have	emotional	disturbance	later	in	life	(14).		310	 	311	 A	rapid	diagnosis	is	essential	to	rule	out	other	causes	of	meningitis.	Our	study	aimed	312	 to	determine	the	proportion	of	meningitis	due	to	common	viral	pathogens	in	children	313	 over	two	months	of	age	using	molecular	diagnostic	techniques.	314	 	315	
	316	
Definition	of	meningitis	and	encephalitis	317	
	318	 Meningitis	is	defined	as	inflammation	of	the	meninges	which	manifests	by	an	319	 increased	number	of	white	cells	in	the	cerebrospinal	fluid	(7).	It	can	be	320	 differentiated	into	bacterial	and	aseptic	meningitis.	Common	bacterial	causes	also	321	 include	Neisseria	meningitidis,	Haemophilus	influenzae	type	b,	Streptococcus	322	
pneumoniae	and	Mycobacterium	tuberculosis	whereas	aseptic	meningitis	includes	323	 viral,	fungal	and	other	causes.	324	 VM	constitutes	a	large	number	of	aseptic	meningitis	hence	the	term	is	commonly	used	325	
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to	describe	aseptic	meningitis	as	it	is	the	most	common	cause	of	raised	white	cell	326	 count	in	the	majority	of	cases.		By	definition,	viral	meningitis	is	a	type	of	meningitis	327	 due	to	a	viral	infection	(15).		It	is	a	clinical	syndrome	of	meningeal	inflammation	by	328	 viruses	with	negative	CSF	cultures	for	routine	bacterial	pathogens	in	a	patient	who	did	329	 not	receive	antibiotics	before	lumbar	puncture(7).		The	common	viral	causes	of	330	 meningitis	that	we	see	are	enteroviruses,	herpes	simplex	virus	and	mumps	virus.	331	 Sometimes	it	is	difficult	to	differentiate	between	meningitis	and	encephalitis	in	our	332	 patients.		333	 	334	 The	term	encephalitis	refers	to	the	presence	of	an	inflammatory	process	in	the	335	 central	nervous	system	and	is	usually	accompanied	by	clinical	evidence	of	336	 neurological	dysfunction	such	as	encephalopathy	and	seizures.	When	the	condition	337	 is	affecting	the	meninges	it	is	then	referred	to	as	meningoencephalitis.	Both	338	 encephalitis	and	meningoencephalitis	are	grouped	together	as	they	share	same	339	 epidemiology,	aetiology	and	management	(16).	340	
	341	
Causes	of	meningitis	342	 	343	 The	described	commonest	causes	of	meningitis	in	ages	between	two	months	and	344	 13	years	are	summarised	in	table	2.	345	
Table	2:	Major	causes	of	meningitis	in	children	aged	2months	and	13	years	346	
Organism	 Common	 uncommon	
Bacteria	 Neisseria	meningitidis,	Haemophilus	influenzae	
type	b,	Streptococcus	pneumoniae	
	
Viruses	 Enteroviruses		Herpes	Simplex	Virus	 Mumps		HIV	
Fungi	 	 Cryptococcus	neoformans	
Other	causes	 Parasites,	Drugs,	Malignancy,	Auto-immune	 	
19		
		 	 	
Adapted	from:	Sawyer	MH,	Rotbart	HA.	Aseptic	and	viral	meningitis.	In:	Principles	and	Practice	of	347	
Pediatric	Infectious	Diseases,	3rd	ed,	Long	SS,	Pickering	LK,	Prober	CG	(Eds),	Churchill	Livingstone,	348	
New	York	2008.	Copyright	©	2008	Elsevier.	349	
	350	
	351	
Epidemiology	of	meningitis	352	
	353	 Viral	meningitis	has	been	recognised	for	years	both	internationally	and	locally	354	 however	there	has	been	a	huge	change	in	causative	organism.	Before	the	1960s,	355	 mumps	and	measles	were	the	most	common	causes	of	viral	meningitis	that	were	356	 reported.	In	1963	measles	vaccine	was	introduced	followed	by	mumps	vaccine	in	357	 1967.		Since	then,	the	enteroviruses	have	taken	a	lead	in	viral	causes	of	meningitis	(17,	358	 18).	Researchers	in	the	United	States	have	also	shown	similar	results	to	South	Africa	359	 where	they	documented	most	cases	of	viral	meningitis	and	infant	febrile	syndromes	to	360	 be	due	to	enteroviruses	(19-21).		361	 	362	 	363	 Enteroviruses	can	be	associated	with	outbreaks	especially	during	hot	months	(21).	364	 Outbreaks	of	echovirus	(EV	family)	meningitis	were	also	reported	from	Johannesburg	365	 and	from	Worcester.		In	1957,	in	a	Johannesburg	Children's	Home,	58	of	121	children	366	 became	ill	in	the	first	3months.	Some	children	had	clinical	features	of	viral	meningitis.	367	 Virus	studies	were	carried	out	in	18	children	of	whom	10	had	confirmed	viral	368	 infection	,	isolated	from	the		stool	in	3	and	cerebrospinal	fluid	in	7	children	(22).	Echo	369	 virus	Type	4	was	also	isolated	in	children	and	staff	members	from	a	school	for	the	370	 deaf	and	blind	at	Worcester	in	the	Cape	Province	during	June	1960.	A	total	of	204	out	371	 of	482	cases	were	reported	for	the	period	6	-	19	June	(23).			372	 Viral	meningitis	is	self-limiting	and	is	not	the	cause	of	any	great	mortality	or	373	
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morbidity	(12).	In	a	study	done	by	Beghi	et	al.	in	Minnesota,	recovery	from	VM	was	374	 reported	at	the	end	of	the	acute	phase	in	95%	of	patients	and	there	were	no	deaths	375	 (24).		Potter	et	al.	reported	similar	findings	where	they	noted	very	low	morbidity	376	 and	death	to	be	extremely	rare	(12).			377	 	378	 For	years	researchers	focused	on	bacterial	meningitis	because	of	its	huge	burden	of	379	 disease.	The	aim	was	to	find	ways	to	decrease	morbidity	and	mortality	that	is	caused	380	 by	those	organisms.	Researchers	in	Bahrain	assessed	the	trend	in	the	incidence	of	381	 bacterial	meningitis	from	1990	to	2013,	before	and	after	the	introduction	of	new	382	 vaccines.	They	reported	1455	cases	of	meningitis	during	the	study	period	of	which	383	 1051	(73.1%)	were	viral	and	386	(26.9%)	were	bacterial	in	aetiology	with	384	
Mycobacterium	tuberculosis	causing	the	highest	number	of	BM	cases	-122	(8.5%).	385	 Between	1995	and	1996	they	observed	a	peak	in	cases	of	bacterial	meningitis.	After	386	 the	introduction	of	H.	influenzae	and	Neisseria	meningitidis	vaccines	in	1998	and	387	 2001	there	was	a	drop	in	cases	of	H.	influenzae	and	Neisseria	meningitidis	meningitis;	388	
Streptococcus	pneumoniae	was	noted	to	be	the	predominant	organism	after	389	 Mycobacterium	tuberculosis	(25)	.	390	 	391	 The	available	South	African	studies	showed	viral	meningitis	to	be	the	leading	cause	392	 of	meningitis	followed	by	tuberculous	meningitis	(TBM).	A	small	proportion	of	393	 patients	with	suspected	viral	meningitis	may	need	to	be	screened	for	TBM.	Whilst	394	 the	lymphocytes	are	elevated	in	both,	clinical	presentation	and	CSF	protein,	and	395	 glucose,	will	also	influence	the	diagnosis.	There	are	other	important	factors	that	are	396	 taken	into	account	when	a	diagnosis	of	TBM	is	being	considered	e.g.	the	history	of	a	397	 household	contact	with	tuberculosis,	the	presence	of	growth-faltering,	a	longer	398	
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period	of	unwellness,	evidence	of	tuberculosis	infection	elsewhere	such	as	a	chronic	399	 cough	and	chest	radiograph	that	is	suggestive	of	tuberculosis,	the	presence	of	a	400	 strongly	reactive	Mantoux	test,	and	clinical	features	that	would	support	stage	two	or	401	 three	of	TBM	(26).		402	 	403	 Between	July	1981	and	June	1984,	1223	cases	of	meningitis	were	seen	in	the	404	 Department	of	Paediatrics,	Tygerberg	Hospital.	Aseptic	meningitis	was	found	to	be	405	 the	commonest	form	of	meningitis	in	each	population	group	contributing	towards	406	 739/1223	(60.	4%)	of	cases	of	meningitis	of	which	108/739(14.6%)	cases	were	407	 due	to	viruses.		In	the	first	two	years	enteroviruses	were	responsible	for	the	cases	408	 of	VM	but	then	mumps	became	prominent	afterwards.	For	confirmed	bacterial	409	 meningitis	the	commonest	cause	was	Neisseria	meningitidis	(140	cases;	11.5%)	410	 followed	by	tuberculosis	which	was	responsible	for	62	cases	of	meningitis	(5%)	411	 and	then	H.	influenzae	(47	cases)	and	lastly	Streptococcus	pneumoniae	(34	cases)	412	 (26)	.	413	 	414	 Between	1985	and	1993	before	the	introduction	of	Hib	vaccine	and	PCV,	a	415	 prospective	survey	was	carried	out	of	all	cases	of	meningitis	in	children	under	the	416	 age	of	13	years	presenting	to	Tygerberg	hospital	in	the	Western	Cape	Province	of	417	 South	Africa.	There	were	2920	cases	of	meningitis	identified	whereby	the	most	418	 common	form	of	bacterial	meningitis	was	TBM	diagnosed	in	282	(9.7%)	children	419	 followed	by	N.	meningitidis	in	220	(7.5%)	children,	Haemophilus	influenzae	in	156	420	 (5.3%)	children	and	Streptococcus		pneumoniae	in	106	(3.6%)	respectively	(27).		421	 	422	 	423	
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A	follow	up	study	at	the	same	institution	showed	that	TBM	was	more	common	424	 despite	the	introduction	of	antiretroviral	therapy	(ART),	followed	by	N.	meningitidis,	425	
Haemophilus	influenzae	and	lastly	S.	pneumoniae	(27).	A	further	follow	up	study	was	426	 conducted	between	2007-2009,	after	the	introduction	of	the	Haemophilus	influenzae	427	
type	b	vaccine	in	July	1999	and	pneumococcal	vaccine	in	2009.	A	decline	in	bacterial	428	 meningitis	cases,	excluding	S.	pneumoniae	was	noted.	They	reviewed	a	total	of	557	429	 cases	of	children	older	than	3	years	of	age.	VM	was	still	the	leading	cause	followed	by	430	 TBM	which	accounted	for	126	(22%),	S.	pneumoniae	in	23	(4%)	cases,	Klebsiella	431	
pneumoniae	in	17	(3%)	cases	and	lastly	Haemophilus	influenzae	in	3	(<1%)	cases	432	 reflecting	the	impact	of	Hib	vaccine	(8,	27).		433	 	434	 Other	similar	studies	that	were	conducted	in	South	Africa,	Cape	Town	showed	a	435	 higher	prevalence	of	TBM	and	an	association	with	poor	outcomes	in	certain	436	 population	groups	e.g.	HIV	infected	and	African	population	(28-29).	Different	South	437	 African	studies	have	described	a	significant	difference	in	prevalence	of	meningitis	in	438	 communities	of	different	socio-economic	groups	(26,	30).	N.	meningitidis	was	found	to	439	 be	common	in	coloured	children,	H.	influenzae	in	white	children	and	TBM	in	black	440	 children	(26).	441	 	442	 Figure	1	summarises	causes	of	meningitis	in	South	Africa	from	1957	to	1997.	Not	all	443	 studies	looked	at	viral	causes	of	meningitis	as	the	focus	was	on	BM.	We	can	appreciate	444	 the	high	prevalence	of	Haemophilus	influenzae	meningitis	and	a	drop	after	the	445	 introduction	of	the	Hib	vaccine.	S.	pneumoniae	and	N.	meningitidis	then	became	the	446	 leading	causes	afterwards.		Current	data	shows	a	decline	in	cases	of	invasive	447	 pneumococcal	disease	but	the	HIV-infected	population	still	gets	more	affected	that	the	448	
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HIV	negative	(31).	449	 	450	
	451	 	452	
Figure	1:	Causes	of	meningitis	in	South	African	children	1957-1997	453	
	454	
Clinical	picture	of	meningitis		455	
	456	 The	 clinical	 presentation	 of	 VM	 is	 generally	 similar	 to	 that	 of	 BM,	 but	 is	 often	 less	457	 severe.	VM	may	be	suspected	based	on	 the	epidemiologic	data,	clinical	 features	and	458	 initial	cerebrospinal	fluid	(CSF)	studies	(21).		459	 	460	 Fever	and	vomiting	are	usually	the	most	frequent	reasons	for	consulting	a	physician	but	461	 it	 can	 be	 a	 presenting	 sign	 for	 common	 viral	 illnesses,	 such	 as	 influenza.	 Other	462	 presenting	signs	and	symptoms	may	include	nausea,	muscle	and	joint	pain,	breathing	463	 difficulties,	and	loss	of	appetite.	Meningitis	should	be	suspected	in	irritable	or	lethargic	464	
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febrile	children	despite	the	absence	of	neck	rigidity	(37).	465	 	466	 Clinical	manifestations	may	also	vary	according	to	the	age,	immune	status	of	the	patient	467	 as	well	as	 the	aetiological	agent(7).	Older	children	may	present	with	acute	onset	of	468	 fever,	headache,	nausea,	vomiting,	stiff	neck,	and	photophobia.	de	Crom	and	Michos	469	 described	 the	 same	 clinical	 presentation,	 they	 also	 reported	 additional	 non-specific	470	 symptoms	of	malaise,	irritability	and	sometimes	abdominal	pain	(38,	39).			471	
	472	 Physical	findings	in	neonates	and	older	children	are	variable.	Neonates	can	either	have	473	 normal	 clinical	 examination,	have	very	non-specific	 signs	 like	 irritability,	 apnoea	or	474	 they	can	have	a	bulging	fontanelle.	Older	children	can	present	systemic	manifestations	475	 like	 rash,	 conjunctivitis,	 pharyngitis,	 and	diarrhoea	which	may	provide	 clues	 to	 the	476	 underlying	 viral	 aetiology.	 Other	 signs	 of	 meningitis	 may	 be	 decreased	 level	 of	477	 consciousness,	Brudzinski	and	Kerning’s	signs	(	40).	478	 	479	 Viral	meningitis	is	a	self-limiting	disease;	the	vast	majority	of	patients	recover	in	1-480	 2	weeks.	About	5%	of	patients	have	residual	deficits	including	fatigue,	mild	481	 cognitive	impairments,	seizures	and	cranial	nerve	palsies.	The	most	severe	482	 complications	are	those	described	with	herpes	virus	infection	including	the	483	 progression	to	severe	encephalitis,	or	the	development	of	other	organ	involvement	484	 such	as	liver	or	myocardial	necrosis	(40).	485	
	486	
	487	
	488	
	489	
Diagnosis	and	Management	approach	to	meningitis	490	
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	491	 The	clinical	picture	alone	is	not	enough	to	diagnose	viral	meningitis.	Patients	need	a	492	 lumbar	puncture	however	the	CSF	profiles	of	bacterial	and	viral	meningitis	often	493	 overlap,	particularly	during	the	earliest	stages	of	viral	meningitis	further	making	494	 the	differentiation	difficult	(39).	Table	3	summarizes	clinical	case	definitions	of	495	 meningitis	according	to	the	Centre	for	Disease	Control	and	Prevention	(CDC).	496	 	497	
Table	3:	Recommended	case	definitions	of	meningitis	498	
	 Viral	meningitis	 Bacterial	meningitis	
Definition	of	meningitis	 Is	a	syndrome	characterized	by	acute	onset	of	meningeal	symptoms,	fever,	and	cerebrospinal	fluid	pleocytosis,	with	bacteriologically	sterile	cultures	
Manifests	most	commonly	with	fever,	headache,	and	a	stiff	neck;	the	disease	may	progress	rapidly	to	shock	and	death.	However,	other	manifestations	may	be	observed.	
Laboratory	criteria	for	
diagnosis	
No	evidence	of	bacterial	or	fungal	meningitis	 Isolation	of	a	bacterial	species	from	the	cerebrospinal	fluid	
Confirmed	case	 A	clinically	compatible	case	diagnosed	by	a	physician	as	aseptic	meningitis,	with	no	laboratory	evidence	of	bacterial	or	fungal	meningitis.	
A	clinically	compatible	case	that	is	either	laboratory	confirmed	or	is	accompanied	by	a	positive	blood	culture	
Adapted	from	the	Centre	for	Disease	Control	and	Prevention	499	
(https://www.cdc.gov/mmwr/preview/mmwrhtml/00047449.htm).	500	
	501	 The	introduction	of	new	vaccines	and	antimicrobial	drugs	has	been	a	huge	502	 accomplishment	in	the	field	of	infectious	diseases	especially	in	bacterial	meningitis,	503	 but	there	has	been	very	little	improvement	in	the	diagnostic	methodology	(20,	41).	504	 The	initial	laboratory	evaluation	of	a	child	with	suspected	meningitis	includes	blood	505	 tests	and	CSF	examination.	A	confirmed	diagnosis	of	viral	meningitis	requires	a	506	 positive	identification	of	a	viral	pathogen,	most	often	in	the	context	of	a	negative	CSF	507	 culture	for	routine	bacterial	pathogens.	508	 	509	
	510	
	511	
Laboratory	diagnosis	of	bacterial	meningitis	512	
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	513	 Examination	of	the	CSF	is	necessary	to	establish	a	diagnosis	of	meningitis	and	to	make	514	 a	provisional	diagnosis	of	bacterial,	viral,	or	unclear	aetiology.	A	lumbar	puncture	may	515	 also	provide	symptom	relief	by	relieving	the	accompanying	raised	intracranial	516	 pressure	in	patients	with	viral	meningitis	(42).	CSF	should	be	sent	for	cell	count,	517	 glucose,	chloride,	protein,	gram	stain	and	bacterial	culture.	The	role	of	chloride	in	518	 diagnosing	meningitis	is	still	unclear	and	has	no	bearing	on	the	diagnosis	of	VM.	Viral	519	 culture	and	Polymerase	Chain	Reaction	(PCR)	are	usually	done	if	the	clinical	picture	520	 suggests	viral	meningitis	and	if	the	resources	are	available.	521	 	522	
	523	
CSF	chemistry	and	cell	count	524	
	525	
Table	4	compares	CSF	findings	in	cases	of	bacterial	and	viral	meningitis.	This	does	526	 not	take	the	prior	use	of	antibiotics	into	consideration.	527	 	528	
TABLE	4	--	Cerebrospinal	Fluid	Analysis	in	Bacterial	and	Viral	Meningitis.*	
FINDING	 Bacterial	Meningitis	 Viral	Meningitis	Opening	pressure	 Usually	elevated	 Usually	normal	WBC	count/mm3	 Elevated,	500–10,000+	 Elevated,	6–1000	Differential	count	 Polymorphonuclear	predominance	 Lymphocytic	predominance	Glucose	level	 Decreased,	0–40	mg/dL	 Usually	normal	Protein	level	 Elevated,	>50	mg/dL	 Normal	or	slightly	elevated	
Adapted	from	Fong	B,	Van	Bendegem	J:	Lumbar	puncture.	In	Reichman	E,	Simon	R	(eds):	Emergency	Medical	Procedures.	New	
York:	McGraw-Hill,	2004,	p	875.	*This	is	only	a	guide	and	care	must	be	taken	when	interpreting	these	parameters,	especially	early	in	
the	clinical	course.	
	529	 The	level	of	glucose	in	viral	meningitis	is	usually	normal	but	a	slight	decrease	is	530	
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not	uncommon.	In	cases	of	TBM,	fungal	and	bacterial	meningitis,	it	is	very	low	531	 (43).	532	 	533	 In	patients	who	did	not	receive	antibiotics	before	LP	is	done;	CSF	white	blood	cell	534	 count	can	be	a	useful	and	rapid	diagnostic	tool	to	distinguish	between	BM	and	VM	in	535	 children	only	(44).Certain	authors	recommend	that	when	in	doubt,	the	patients	must	536	 be	admitted	for	intravenous	antibiotics	pending	the	CSF	culture	results	or	admit	for	537	 observations	and	repeat	LP	in	24	hours	(45).	538	 	539	 In	viral	meningitis	one	may	find	mildly	elevated	CSF	protein	with	normal	glucose.	The	540	 pleocytosis	in	VM	shows	a	predominance	of	lymphocytes.	Although	the	differential	541	 diagnosis	includes	TBM;	the	CSF	in	TBM	usually	has	low	glucose	with	significantly	542	 raised	protein.	When	in	doubt	in	the	absence	of	viral	culture	and	PCR,	TB	screening	is	543	 recommended	before	calling	it	VM	(46,	47).	544	 	545	 There	have	been	cases	of	VM	that	presented	with	polymorphonuclear	cell	546	 predominance	and	that	makes	it	difficult	to	distinguish	it	from	BM.	This	has	been	547	 reported	to	happen	early	during	VM	as	confirmed	by	Thomson	Jr	et	al.	who	548	 reported	cases	of	viral	infections	like	herpes,	enterovirus	and	arbovirus	which	549	 were	reported	to	have	predominance	in	polymorphonuclear	(PMN)	leucocytes	550	 during	the	first	48	hours	(48).	This	is	when	history	taking	becomes	crucial	so	that	551	 one	can	correlate	symptoms	with	the	CSF	findings	and	if	in	doubt	then	patients	552	 are	treated	pending	the	CSF	culture	results.	553	 	554	 Confusion	was	reported	by	Potter	et	al.		in	his	survey	done	in	Cape	Town,	South	Africa	555	
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of	213	children	who	presented	with	meningitis	during	winter	months.	At	that	time	556	 there	was	an	enterovirus	outbreak	but	still	the	most	common	cause	of	meningitis	was	557	
N.	meningitidis.	Most	concerning	was	that	there	was	no	difference	in	the	initial	CSF	558	 findings	of	both	EV	meningitis	and	those	of	N.	meningitidis.	Those	who	had	purulent	559	 CSF	with	PMN	predominance	actually	did	not	have	BM	and	they	recovered	quickly	560	 (12).	CSF	should	not	have	any	erythrocytes	unless	there	is	a	bloody	tap	or	in	cases	of	561	 head	trauma	/haemorrhage.	562	 	563	 In	developing	countries	like	South	Africa,	the	most	commonly	used	approaches	for	564	 the	detection	and	characterization	of	bacterial	meningitis	pathogens	include	565	 bacterial	culture	and	Gram	stain	(49).	Viral	cultures	are	however	not	available	in	566	 most	hospitals.	567	
	568	
Gram	stain	569	
	570	 CSF	Gram	staining	is	a	rapid,	inexpensive,	and	requires	relatively	little	571	 training.	It	simply	gives	a	clue	as	to	the	genus	and	species	of	the	aetiological	572	 agent.	However,	accurate	results	are	highly	dependent	on	the	operator’s	573	 staining	and	interpretation	skills.	It	has	been	long	considered	a	mainstay	of	574	 bacterial	meningitis	diagnosis.	Previous	studies	report	Gram	stain	575	 sensitivities	as	high	as	90%	and	specificities	of	97%	or	more	(50).	In	a	576	 different	study	Gram	stain	had	a	sensitivity	of	98.2%	and	specificity	of	98.7%	577	 (51).	578	
	579	 	580	 Gram	stain	results	are	also	subject	to	observer	misinterpretation,	therefore	581	
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broad-	spectrum	antimicrobial	therapy	should	be	continued	until	CSF	culture	582	 results	are	available.	It	is	reported	as	Gram-positive	diplococci	for	S.	pneumoniae,	583	 Gram-negative	diplococci	for	N.	meningitidis	and	Gram-negative	coccobacilli	for	584	 Hib	(52).	585	 	586	
Culture	587	
	588	 Bacterial	Culture	589	 	590	 Isolation	of	a	bacterial	pathogen	from	the	CSF	culture	confirms	the	diagnosis	of	591	 bacterial	meningitis.	However,	a	negative	culture	of	the	CSF	at	a	particular	point	in	592	 time	does	not	exclude	meningitis	if	CSF	was	taken	too	early	of	if	taken	after	giving	the	593	 patient	antibiotics.	The	positive	rate	is	relatively	low	due	administration	of	594	 antibiotics	prior	to	lumbar	puncture.	CSF	culture	sensitivities	have	been	reported	to	595	 range	from	70%	to	90%.	Bacterial	culture	yield	may	vary	based	on	patient	596	 characteristics,	laboratory	practices,	CSF	volume	and	spectrum	of	bacterial	597	 pathogens	likely	contributing	to	the	observed	differences	(51).		598	 	599	 Kanegaye	et	al.	demonstrated	that	CSF	sterilization	may	occur	more	rapidly	after	600	 initiation	of	parenteral	antibiotics,	with	complete	sterilization	of	meningococcus	601	 within	two	hours	and	the	beginning	of	sterilization	of	pneumococcus	by	four	hours	602	 into	therapy	(53).	Nigrovic	and	collaborators	looked	at	159	patients	with	BM	who	603	 had	not	been	treated	with	antibiotics.	Antibiotics	dropped	CSF	culture	sensitivity	by	604	 15%	with	the	sensitivity	of	84%	in	patients	who	had	not	received	antibiotics	before	605	 LP	and	59%	in	those	who	had	antibiotics	before	LP	(54).	606	 Lack	of	adequate	culture	material	may	result	in	inability	to	tailor	therapy	to	607	
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antimicrobial	susceptibility	or	in	unnecessarily	prolonged	treatment	if	the	clinical	608	 presentation	and	laboratory	data	cannot	exclude	the	possibility	of	bacterial	609	 meningitis.	Kanagaye	et	al.	recommend	that	if	the	child	is	stable;	LP	should	be	done	610	 before	giving	antibiotics	if	the	facility	has	resources	to	do	so	(53).	611	 	612	 Viral	cultures	613	 	614	 For	children	in	whom	viral	meningitis	is	suspected,	CSF	viral	culture	is	important.	615	 Stool	and	throat	swabs	may	be	sent	for	viral	culture	if	available	(55).	Viral	cultures	616	 are	not	routinely	done	at	Red	Cross	War	Memorial	Children’s	Hospital.	A	diagnosis	617	 of	viral	meningitis	is	usually	made	in	the	absence	of	bacterial	meningitis.	618	 	619	
Polymerase	Chain	Reaction	(PCR)		620	
	621	 Polymerase	Chain	Reaction	(PCR)	was	developed	in	the	mid-	to	late	1980s	and	is	622	 considered	one	of	the	most	important	methodological	inventions	in	molecular	623	 biology.	It	is	designed	to	permit	selective	amplification	of	a	specific	target	DNA	624	 sequence(s)	within	a	heterogeneous	collection	of	DNA	sequences	(56).	625	 	626	 PCR	sensitivity	has	been	shown	to	be	superior	to	that	of	tissue-culture	isolation	for	627	 both	bacteria	and	viruses.	It	is	however	very	selective	and	detects	only	those	628	 pathogens	for	which	primers	have	been	designed.	Therefore,	a	negative	test	does	not	629	 exclude	other	pathogens	as	the	cause	of	meningitis.	PCR	can	also	be	compromised	by	630	 false	positive	results	due	to	contamination	and	negative	results	due	to	inhibitors	of	631	 the	amplification	reaction	present	in	the	sample	(57).	632	 	633	
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Khumalo	et	al.	looked	at	the	diagnostic	accuracy	of	two	multiplex	real-time	PCR	assays	634	 for	the	diagnosis	of	meningitis	in	South	African	children.	They	analysed	292	CSF	635	 samples	using	two	multiplex	RT-	PCRs	which	were	developed	to	detect	S.	pneumoniae,	636	
N.	meningitidis,	H.	influenzae,	enteroviruses,	mumps	virus	and	herpes	simplex	virus.	637	 Bacterial	DNA	was	detected	in	12	(4.1%)	and	viral	nucleic	acids	in	94	(32%).		638	 	639	 All	patients	who	tested	culture	positive	for	bacterial	meningitis	were	also	positive	on	640	 RT-PCR;	PCR	also	detected	an	additional	four	cases	which	were	not	picked	up	on	641	 microscopy/culture.	Compared	to	CSF	culture,	the	sensitivity	and	specificity	of	the	642	 bacterial	RT-PCR	was	100%	and	97.2%	with	complete	agreement	in	organism	643	 identification.		None	of	the	cases	positive	by	viral	RT-PCR	had	a	bacterial	cause	644	 confirmed	on	CSF	culture	(58).	645	 	646	 Wu	et	al.	compared	real	time-PCR	to	microscopy	and	culture	results	and	it	was	647	 found	to	be	associated	with	high	sensitivity,	specificity,	and	predictive	values	to	648	 diagnose	bacterial	meningitis	(51).	Table	5	summarises	their	findings	(51,	59).	649	 	650	
	651	
	652	
	653	
	654	
	655	
	656	
	657	
	658	
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Table	5:	Diagnostic	methods	for	identification	of	micro-organism	in	meningitis	659	
Methods	 Sensitivity	 Specificity	 Turn-	
around	
time	
Advantages	 Disadvantages	
Gram	stain	 High	if	not	pre-	treated	with	antibiotics	98.2%	
High	
	
	 98.7%	
Hours	 • Quick	
• Cheap	 • Operator	dependent	• Prior	antibiotic	lowers	the	sensitivity	
• Cannot	serotype	the	organism	
CSF	culture	 Low	81.3%	 High	99.7%	 48	hours	or	more	 • Specific	• Identifies	a	wider	range	of	organisms	
• Tests	antibiotics	sensitivity	
• Prior	antibiotic	lowers	the	sensitivity	
Bacterial	
Meningitis	
Score*	
Low	 Low	 Hours	 • Quick	 • Not	diagnostic	
• Not	applicable	if	pre-	treated	with	antibiotics	
• Not	for	neonates	
• Not	for	immunocompromised	
PCR	 95.7%	 94.3%	 Hours	 • Quick	detection	
• Reduced	contamination	risk	
• Expensive	
• Identifies	a	limited	number	of	organisms		
Adapted	from	Wu	et	al.	(2013)	and	Nigrovic	et.al	(2012)	660	 	661	 The	main	risk	factor	for	being	culture-negative	and	PCR-positive	is	the	presence	of	662	 antibiotic	in	CSF	(59).	PCR	can	detect	many	of	the	pre-treated,	culture-negative	663	 cases	of	meningitis	(60,	61).	If	PCR	is	available	then	culture	is	only	needed	for	664	 testing	bacterial	sensitivity	to	antibiotics	(62).	665	 	666	 PCR	has	a	quick	turn-around	time	compared	to	culture	(5	to	24	hours	compared	667	 with	4	to	8	days)	(63).		PCR-based	assays	have	become	accessible	to	some	South	668	 African	hospitals	especially	in	private	practice	to	provide	a	rapid	and	accurate	669	 diagnosis	of	bacterial	and	viral	meningitis.	670	 	671	 Few	international	studies	done	on	CSF	PCR	have	shown	a	decrease	in	patient	hospital	672	 length	of	stay	therefore	avoiding	inappropriate	exposure	to	antibiotics.	It	has	also	673	
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been	highly	recommended	particularly	during	the	epidemic	seasons	(39,	64-66).	674	 	675	 PCR	may	also	be	performed	on	blood,	urine	and	stool,	especially	if	CSF	is	not	676	 obtainable.	Positive	PCR	in	these	specimens	may	suggest	a	positive	CSF	PCR	provided	677	 that	the	patient	is	outside	the	neonatal	period	and	there	was	no	use	of	antibiotics	678	 before	the	specimen	is	collected	(67).	679	 	680	 Stool	is	also	the	preferred	specimen	in	cases	of	suspected	aseptic	meningitis	in	a	681	 paediatric	clinic	because	the	sampling	is	not-invasive.	Enteroviruses	are	682	 transmitted	through	the	intestine	so	one	would	expect	high	viral	load	in	the	stool	683	 sample.	If	only	stool	is	available,	PCR	as	well	as	cell	culture	are	valuable;	on	the	684	 contrary,	if	CSF	is	available	cell	culture	is	significantly	superior	to	PCR	in	attaining	685	 a	positive	result	(39,	68,	69).	686	
	687	
Challenges	with	the	diagnosis	of	meningitis	688	
	689	 Integrated	Management	of	Childhood	Illnesses	(IMCI)	690	 	691	 Development	of	a	strategy	of	Integrated	Management	of	Childhood	Illness	(IMCI)	692	 was	started	by	World	Health	Organisation	(WHO)	and	The	United	Nations	Children’s	693	 Fund	(UNICEF)	in	1992.	Its	main	objective	was	to	reduce	mortality	and	morbidity	694	 associated	with	the	major	causes	of	childhood	illness.	At	that	time,	it	was	estimated	695	 that	about	10million	children	die	before	reaching	their	fifth	birthday.	The	vast	696	 majority	of	deaths	occurred	in	the	developing	world	and	are	due	to	acute	697	 respiratory	infections,	diarrhoeal	diseases,	malaria	measles	and	malnutrition	(70).	698	 	699	
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The	 focus	was	mainly	 on	 the	 primary	 health	 services	which	 are	 the	 first	 point	 of	700	 contact	 for	 sick	 patients.	 It	 did	 not	 make	 sense	 to	 only	 focus	 on	 the	 above	 five	701	 conditions,	 other	 common	 life-threatening	 conditions	 (including	 meningitis)	 were	702	 also	included	in	their	guidelines	and	the	first	version	was	completed	in	1995.	In	a	case	703	 of	 suspected	meningitis	 IMCI	 suggests	urgent	 treatment	with	 injectable	 antibiotics	704	 and	referral	to	the	hospital.	This	has	been	done	to	mitigate	against	delaying	antibiotics	705	 which	has	an	impact	in	the	outcome	of	BM.	706	 	707	 Antibiotics	use	before	doing	a	lumbar	puncture	708	 	709	 The	probability	of	visualising	bacteria	on	a	Gram	stained	preparation	of	CSF	is	710	 dependent	on	the	number	of	organisms	present.	In	most	cases	antibiotics	either	711	 given	orally	or	intravenously	would	kill	the	majority	of	those	bacteria	hence	712	 lowering	rates	of	Gram	stain	and	culture	and	this	may	occur	within	hours.	This	can	713	 drop	the	yield	of	positive	CSF	cultures	from	70%-85%	to	below	50%	in	patients	714	 (especially	in	meningococcal	infection),	but	the	CSF	inflammatory	indices	do	not	715	 often	change	significantly	(71).	716	 	717	 Although	the	use	of	antimicrobial	therapy	before	LP	affects	the	CSF	culture	and	718	 perhaps	the	Gram	stain,	conventional	teaching	has	been	that	a	pathogen	still	can	be	719	 identified	in	the	CSF	in	the	majority	of	patients	up	to	several	hours	after	the	720	 administration	of	antibiotics.	Kanegaye	et	al.		reported	that	in	the	case	of	721	 meningococcus,	sterility	occurred	as	early	as	two	hours	after	antibiotic	therapy	with	722	 a	3rd	generation	cephalosporin	and	for	S.	pneumoniae	after	four	hours	of	antibiotic	723	 therapy	(53).	724	
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A	review	of	128	children	with	bacterial	meningitis	specifically	addressed	this	725	 question	and	found	that	the	time	interval	between	antibiotic	administration	and	726	 negative	CSF	cultures	may	be	shorter	than	appreciated	for	children	who	receive	727	 parenteral	antibiotics	(53).	Oral	antibiotics	have	been	reported	to	have	minimal	728	 effects	on	CSF	cytology	(70,	71).	729	 	730	 In	order	to	screen	patients	and	avoid	unnecessary	admissions,	Nigrovic	came	up	731	 with	a	Bacterial	Meningitis	Score	(BMS).	It	is	a	clinical	predictive	model	which	can	732	 be	used	in	an	emergency	room	to	screen	patients	who	are	at	low	risk	of	bacterial	733	 meningitis.	It	can	be	used	in	children	with	increased	white	cell	count	in	the	CSF.	734	 Children	are	classified	as	low	risk	for	bacterial	meningitis	if	they	lack	the	following:	735	 positive	CSF	Gram	stain,	CSF	absolute	neutrophil	count	≥1000	cells/microL,	CSF	736	 protein	≥80	mg/dL,	peripheral	blood	absolute	neutrophil	count	≥10,000	737	 cells/microL	and	history	of	seizure	before	or	at	the	time	of	presentation	(72).	738	 	739	 The	sensitivity	and	specificity	of	the	BMS	for	bacterial	meningitis	were	99.3	percent	740	 (95%	CI	98.7-99.7	percent)	and	62.1	percent	(95%	CI	60.5	to	63.7	percent),	741	 respectively	when	it	was	tested	in	a	meta-analysis	of	data	from	eight	validation	742	 studies	(one	of	which	was	prospective)	including	5312	patients.	A	negative	BMS	has	743	 a	negative	predictive	value	(NPV)	for	bacterial	meningitis	of	99.9%.	This	suggests	744	 that	the	BMS	may	be	used	in	conjunction	with	clinical	judgment	to	identify	children	745	 with	CSF	pleocytosis	who	are	at	very	low	risk	of	bacterial	meningitis	and	can	be	746	 discharged	from	the	emergency	room	(59).	747	
	748	 The	 use	 of	 BMS	 is	 however	 limited	 especially	 in	 our	 context	 as	 it	 has	 not	 been	749	
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validated	in	children	<	2	months	old,	those	pre-treated	with	antibiotics,	those	with	750	 critical	 illness,	 purpura,	 ventriculo-peritoneal	 shunt,	 recent	 neurosurgery	 or	751	 immunosuppression	 (65,	 72).	 Our	 other	 problem	 is	 the	 prevalence	 of	 HIV	 and	752	 malnutrition	in	our	country	(73).	753	 	754	 Traumatic	Lumbar	Punctures	755	 	756	 Another	challenge	we	face	is	the	high	number	of	traumatic	CSF	taps	that	occur	due	757	 to	the	fact	that	these	patients	may	either	present	at	night	when	doctors	do	LPs	in	a	758	 hurry	because	of	the	workload,	lack	of	sedation	and	different	levels	of	experience	759	 by	doctors.	Traumatic	LP	is	common	and	it	occurs	when	the	spinal	needle	760	 penetrates	the	vascular	epidural	space	and	blood	contaminates	CSF	sample.	761	 Traumatic	LPs	also	make	interpretation	of	the	WBCs	(especially	lymphocytes)	of	762	 the	CSF	sample	difficult	since	it	is	more	likely	that	some	WBCs	in	the	CSF	sample	763	 are	from	the	blood	rather	than	arising	from	meningeal	inflammation.	Children	with	764	 a	traumatic	LP	are	often	treated	presumptively	for	meningitis	pending	results	of	765	 CSF	culture	or	a	repeat	LP	after	48	hours.	Even	with	a	positive	culture	it	is	unclear	766	 whether	one	is	culturing	blood	or	CSF.	767	 	768	 There	are	suggested	methods	which	can	help	with	the	interpretation	of	a	CSF	sample	769	 after	a	traumatic	LP.	True	CSF	WBC	can	be	predicted	comparing	the	ratio	of	WBC:	770	 RBC	in	the	peripheral	blood	with	that	of	the	CSF.	One	formula	for	predicted	CSF	771	 leucocytes	is	=CSF	erythrocytes*	(blood	leucocytes/blood	erythrocytes).	True	CSF	772	 leucocytosis	is	confirmed	if	the	observed	CSF	WBC	count	exceeds	the	predicted	773	 count.	Patients	who	have	history	of	head	trauma,	haemorrhagic	stroke,	and	774	
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necrotizing	encephalitis	are	excluded	in	this	formula	(74).	775	 	776	 Alternatively	in	the	absence	of	data	on	blood	erythrocytes	and	leucocytes,	when	the	777	 CSF	is	not	grossly	blood	stained	using	simple	leucocyte:	erythrocyte	ratio,	we	778	 subtract	1	WBC	for	every	1000	RBCs/microL.	However,	none	of	the	formulae	to	779	 correct	the	number	of	CSF	WBC	obtained	in	a	traumatic	tap	can	be	used	with	total	780	 confidence	to	exclude	meningitis	(75,	76).	781	 	782	 The	CSF	protein	is	also	increased	in	children	with	traumatic	LP	because	of	the	783	 increased	protein	concentration	in	plasma	and	the	release	of	proteins	from	lysed	784	 RBC.	In	children	with	traumatic	LP	the	CSF	protein	concentration	may	be	corrected	785	 by	subtracting	1	mg/dL	for	every	1000	RBCs/microL	(77,	78).	786	 	787	
CSF	co-infection	with	a	virus	and	bacteria	788	
	789	 There	have	been	issues	raised	regarding	co-infection	in	cases	of	meningitis	but	it	is	790	 known	that	CSF	is	a	sterile	fluid.	The	only	time	this	would	be	a	possibility	would	be	791	 in	cases	of	head	trauma	or	patients	with	a	foreign	body	such	as	ventriculo-peritoneal	792	 shunt.	Nigrovic	et	al.	also	confirmed	that	children	with	CSF	pleocytosis	who	have	a	793	 positive	EV-PCR	result	are	at	a	very	low	risk	of	bacterial	meningitis	and	might	be	794	 safely	treated	as	outpatients,	if	they	appear	well	enough	(79)	.	795	 		796	
	797	
	798	
	799	
	800	
	801	
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Adjunctive	tests	for	meningitis	802	
	803	
CSF	804	
	805	 CSF	lactate	level	has	been	said	to	be	a	good	predictor	of	bacterial	meningitis	at	806	 values	above	3.5	mmol/L.	Like	microscopy	and	culture;	it	can	also	be	affected	by	807	 pre-treatment	with	antibiotics.	Its	routine	use	is	not	yet	recommended	because	808	 further	prospective	studies	are	needed	(80).	809	
Blood	810	
	811	 Initial	blood	tests	for	a	child	with	suspected	meningitis	should	include	blood	812	 cultures,	full	blood	count	(FBC)	with	differential	and	platelet	count	(15,	81).	The	813	 measurement	of	inflammatory	mediators	C-reactive	protein	(CRP)	and	procalcitonin	814	 (PCT)	have	been	evaluated	to	distinguish	between	viral	and	bacterial	meningitis	815	 with	several	studies	showing	PCT	to	be	superior	to	CRP	in	differentiating	between	816	 the	two	(82-84).	While	an	elevation	in	either	CRP	or	PCT	is	more	suggestive	of	817	 bacterial	infection,	neither	can	establish,	nor	exclude	the	diagnosis	of	bacterial	818	 meningitis	(82,	85).	CRP	lacks	the	specificity	although	at	high	levels	above	40	has	819	 been	shown	a	high	specificity	for	invasive	bacterial	infection	including	meningitis	820	 (86).		821	
Table	6:	The	effect	of	inflammatory	markers	in	diagnosis	of	bacterial	meningitis	(38,	87-92)	822	 	 CRP	 PCT	 WBC	
Rise	in	concentration	 Slow	 Hours	 Hours	
Sensitivity	 High	(depends	on	the	time	that	the	sample	will	be	taken)	 High	(	If	between	0.5	and	2	ng/mL)	 High	
Specificity	 High	if	above	40	 High	(	If	between	0.5	and	2	ng/mL)	 Low	
Prognostic	value	 No	 Yes	 No	
Independent	diagnostic	value	 No	 No	 No		823	
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Imaging	824	
	825	 Computed	tomography	(CT)	of	the	head	is	necessary	before	lumbar	puncture	in	826	 patients	with	signs	or	symptoms	of	increased	intracranial	pressure	who	are	at	risk	827	 of	coning.	It	has	however	been	used	more	in	cases	of	bacterial	meningitis	especially	828	 TBM.	Additional	imaging	studies	like	chest	radiograph	in	children	with	a	history	of	829	 exposure	to	Mycobacterium	tuberculosis	may	be	useful	in	selected	patients	(80).	830	 	831	
Meningitis	and	HIV	832	 	833	 Cryptococcal	and	tuberculous	meningitis	remain	a	major	cause	of	morbidity	and	834	 mortality	among	patients	living	with	HIV	in	sub-Saharan	Africa,	and	in	many	cases	it	is	835	 potentially	preventable	(93).			836	
	837	 Paediatric	studies	have	reported	CM	cases	in	HIV-negative	children	too.	It	should	838	 however	still	be	considered	as	a	differential	diagnosis	in	older	children	who	are	839	 HIV-positive	and	have	a	stage	4	defining	illness	(94).	TBM	is	another	differential	840	 diagnosis	for	HIV	positive	patients	presenting	with	meningitis.	Making	a	diagnosis	841	 can	be	a	challenge	especially	in	severely	immunocompromised	patients	(95).	It	has	842	 been	well	studied	locally	and	the	management	guidelines	are	clear.	843	 	844	 In	2005,	WHO	estimated	that	0.7-1	million	children	under	5	years	of	age	in	developing	845	 world	die	of	pneumococcal	disease	every	year	(39).	Mortality	was	shown	to	be	higher	846	 in	the	HIV	positive	population.			A	trial	done	in	Soweto,	South	Africa	showed	a	847	 pneumococcal	vaccine	efficacy	to	be	83%	in	HIV	uninfected	and	65%	in	HIV	positive	848	 group	(93).			849	
40		
Meningitis	treatment	850	 	851	 Meningitis	has	three	diagnostic	categories	which	determine	the	management	of	852	 an	individual	patient	(refer	Table	7):	853	
	854	
Table	7:	Meningitis	diagnostic	categories	and	the	proposed	treatment	(11,	31,	80,	96)	855	
	 Suspected	VM	 Suspected	BM	 Unclear	aetiology	
CSF	glucose	 Normal	 <40	mg/dL	(2.2	mmol/L	 Normal	or	low	
CSF	Protein	 <80	to	100	mg/dL	 >80mg/dL	 Normal	or	high	
CSF	WBC	 <500/microL	with	>50	percent	mononuclear	cells	 >1000/microL	with	a	predominance	of	neutrophils	(PMN)	 PMN	predominance	
CSF	GS	 Negative	 Positive	 Negative	or	delayed	results	
CSF	culture	 Negative	 Positive	 Negative	or	delayed	results	
Prior	treatment	
with	antibiotics	
No	 No	 Yes	
Proposed	
Management	
Supportive	therapy	only:	bed	rest	and	analgesia	 Treatment	with	wide-	spectrum	antibiotics	should	not	be	delayed	while	awaiting	laboratory	results	
Admit,	observe	without	treating	but	if	deteriorates,	treat.	Repeat	LP	in	24-48	hours		(Swingler,	Red	Cross	protocol	2013).	
	856	 As	the	clinical	features	of	encephalitis	can	overlap	with	those	of	meningitis,	all	857	 patients	with	an	acute	onset	of	fever	with	a	change	in	their	mental	status	or	new	858	 onset	of	seizures	(excluding	simple	febrile	seizures)	should	be	treated	for	859	 suspected	herpes	simplex	encephalitis	with	acyclovir	(96).	860	 	861	
	862	
Meningitis	prevention	863	 	864	 Primary	prevention	of	meningitis	predominantly	through	vaccination	programs	865	 is	of	paramount	importance,	since	mortality	and	long-term	disabling	sequelae	866	 remain	substantial.	Routine	vaccination	also	offers	herd	immunity	for	the	867	 unvaccinated	population	(97).	868	
	869	
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Viral	meningitis	870	
	871	 MMR	vaccine	has	been	shown	to	be	effective	in	decreasing	VM	cases	caused	by	872	 mumps	virus.	Improved	public	hygiene	has	also	shown	a	decrease	in	VM	incidence	873	 (18).	874	
	875	
Bacterial	Meningitis	876	
	877	 Since	the	1980s,	many	countries	have	included	immunization	against	Haemophilus	878	
influenzae	type	b	in	their	routine	childhood	vaccination	schemes.	This	has	879	 practically	eliminated	this	pathogen	as	a	cause	of	meningitis	in	young	children	in	880	 those	countries.	In	the	countries	where	the	disease	burden	is	highest,	however,	the	881	 vaccine	is	still	too	expensive	(98).	882	 	883	 Routine	vaccination	against	Streptococcus	pneumoniae	with	the	7-valent	884	 pneumococcal	conjugate	vaccine	(PCV)	in	South	Africa	was	introduced	in	April	2009	885	 and	was	replaced	with	the	13-valent	PCV	in	April	2011.	The	pneumococcal	886	 polysaccharide	vaccine,	which	covers	23	strains,	is	only	administered	in	certain	887	 groups	(e.g.	those	who	have	had	a	splenectomy).	It	does	not	elicit	a	significant	888	 immune	response	in	all	recipients,	e.g.	very	young	children	(98).	889	 	890	 There	is	strong	evidence	that	daily	oral	penicillin	prophylaxis	greatly	reduces	the	891	 risk	of	pneumococcal	infection	in	children	with	sickle	cell	anaemia	under	the	age	of	892	 three	years	and	moderately	strong	evidence	that	its	withdrawal	at	the	age	of	five	893	 years	did	not	result	in	any	serious	consequences	in	Nigeria	(99).	894	 	895	
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Meningococcal	vaccine	is	not	readily	available	in	the	state	sector	in	South	Africa.		As	the	896	 cost	 of	 a	 meningococcal	 vaccine	 programme	 is	 expensive	 and	 the	 prevalence	 of	897	 meningococcal	disease	including	meningitis	is	not	increasing,	some	countries	can	justify	898	 a	 motivation	 for	 certain	 high-risk	 groups	 e.g.	 patients	 with	 asplenia	 and	 other	899	 immunodeficiency	 syndromes	 (100).	 There	 is	 an	 urgent	 need	 to	 have	 guidelines	 for	900	 meningococcal	 vaccination	 for	 high-risk	 groups	 e.g.	 HIV-infected.	 Early	 infant	901	 vaccination	with	BCG	has	been	reported	to	significantly	reduce	the	rate	of	tuberculous	902	 meningitis	in	children	(101,	102).	903	 	904	 	905	
Conclusion	906	 	907	 Viral	meningitis	remains	the	most	common	cause	of	meningitis	amongst	children	with	908	 meningitis	in	hospitals.	Despite	the	revised	South	African	Expanded	Programme	on	909	 Immunisation	there	are	still	cases	of	bacterial	meningitis	and	this,	together	with	the	910	 overlapping	symptoms	and	signs	of	bacterial	and	viral	meningitis,	contributes	to	911	 clinicians	over	diagnosing	BM	because	they	fear	complications.			912	 	913	 Other	complicating	factors	such	as	bloody	CSF	tap	and	prior	exposure	to	antibiotics	914	 affect	our	interpretation	of	CSF	findings	and	CSF	culture	results.		Septic	markers	like	915	 CRP,	PCT	and	FBC	are	expensive	and	have	not	been	shown	to	establish	or	exclude	a	916	 diagnosis	of	bacterial	meningitis.		917	 	918	 Real-time	multiplex	PCR	remains	the	investigation	of	choice	in	diagnosing	meningitis	919	 and	quickly	deciding	which	patients	will	need	admission	for	treatment.	920	
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Abstract	1192	
	1193	
Background	1194	
	1195	
	1196	 Viral	meningitis	is	a	major	cause	of	childhood	meningitis.	Bacterial	meningitis,	1197	 though	a	more	severe	infection	with	high	mortality	rate,	is	relatively	uncommon.		1198	 Routine	cerebrospinal	fluid	microscopy	and	culture	tests	have	low	sensitivity	for	1199	 diagnosing	bacterial	meningitis	particularly	in	the	face	of	antibiotic	administration.	1200	 Many	children	with	viral	meningitis	are	misdiagnosed	and	treated	for	bacterial	1201	 meningitis.	Our	research	explored	the	efficacy	of	polymerase	chain	reaction	(PCR)	1202	 for	diagnosing	meningitis	in	children	older	than	two	months	of	age.	1203	 	1204	
Methods	1205	
	1206	 The	study	included	children	with	an	abnormal	cerebrospinal	fluid	(CSF)	result,	defined	1207	 as	raised	CSF	white	cell	counts,	who	presented	to	the	emergency	unit	of	Red	Cross	War	1208	 Memorial	Children’s	Hospital	(RCWMCH)	between	November	2012	and	October	2013.	1209	 	1210	 Data	obtained	from	patient	records	included	clinical	data	(presentation,	prior	use	of	1211	 antibiotics	and	HIV	status),	blood	culture,	C-reactive	protein	levels	and	routine	1212	 cerebrospinal	fluid	analysis	results	were	reviewed.	PCR	for	bacterial	pathogens	1213	 namely:	Neisseria	meningitidis,	Haemophilus	influenzae	type	b	and	Streptococcus	1214	
pneumoniae	and	viral	pathogens	enterovirus,	herpes	simplex	and	mumps	virus	was	1215	 conducted	on	the	CSF.	1216	
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Results	1217	
	1218	 The	study	included	286	children	with	a	median	age	of	19	months	(IQR=2-65	months).	1219	 Viral	PCR	detected	86	(30.1%)	cases	(enterovirus	=	84,	mumps=2)	while	14	(4.9%)	had	1220	 confirmed	bacterial	meningitis	by	either	PCR	or	routine	culture.	Median	C-reactive	1221	 protein	was	46.2	(19.6	–	173.5)	mg/L	in	confirmed	bacterial	meningitis	and	12.1	(6.0	-	1222	 28.4)	mg/L	in	confirmed	viral	meningitis;	p=0.009.	CSF	chemistry,	cell	counts	were	1223	 similar	in	viral	meningitis	and	bacterial	meningitis.	Forty	(46.5%)	of	the	86	children	1224	 with	confirmed	viral	meningitis	were	initially	treated	as	bacterial	meningitis.	1225	 	1226	
Conclusions	1227	
	1228	 Viral	meningitis	is	the	commonest	cause	of	meningitis	seen	at	RCWMCH	but	most	of	the	1229	 cases	are	wrongly	managed	as	bacterial	meningitis	due	to	poor	diagnostic	confirmation.	1230	 PCR	takes	shorter	time	and	improves	diagnostic	yield	of	viral	meningitis	and	healthcare	1231	 services	should	consider	making	it	standard	of	care.	1232	 	1233	
Introduction	1234	
	1235	
	1236	 Viral	meningitis	(VM)	is	the	leading	cause	of	meningitis	outside	the	neonatal	period	1237	 with	enteroviruses	being	the	most	common	pathogens	(1).	VM	is	usually	a	self-limiting	1238	 illness	but	remains	an	important	cause	of	financial	burden	and	it	requires	1239	 improvement	in	its	diagnostic,	treatment,	and	prevention	options	(2).	1240	 	1241	 	1242	
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On	the	other	hand	bacterial	meningitis	(BM)	is	a	severe	infection	that	can	rapidly	1243	 progress	to	multiple	organ	failure	and	death	if	untreated.		1244	 	1245	 Prior	to	the	introduction	of	vaccines,	BM	was	rated	one	of	the	top	ten	causes	of	death	1246	 among	all	infectious	diseases	and	the	mortality	varies	from	10	to	20%	if	untreated	(3).		1247	 Among	survivors,	up	to	50%	can	have	severe	lifelong	disability.	Permanent	sequelae	1248	 include	hearing	loss,	neurological	disability	and	limb	loss	(4).		The	fear	of	missing	BM	1249	 has	led	to	a	large	proportion	of	children	with	VM	being	misdiagnosed	as	BM	and	1250	 subsequently	receiving	inappropriate	treatment.	1251	 	1252	 Development	of	the	Integrated	Management	of	Childhood	Illness	(IMCI)	strategy	was	1253	 started	by	World	Health	Organisation	(WHO)	and	The	United	Nations	Children’s	Fund	1254	 (UNICEF)	in	1992.	Its	main	objective	was	to	reduce	mortality	and	morbidity	associated	1255	 with	the	major	causes	of	childhood	illness.	In	a	case	of	suspected	meningitis	IMCI	1256	 suggests	urgent	treatment	with	injectable	antibiotics	before	referring	to	the	hospital.	As	a	1257	 result,	these	children	receive	antibiotics	prior	to	CSF	sampling.	1258	 	1259	 Reduction	in	cases	of	Haemophilus	influenzae	has	been	attributed	to	the	introduction	1260	 of	the	Hib	conjugate	vaccine	into	the	Expanded	Programme	on	Immunisation	(EPI)	for	1261	 South	Africa	in	1999	(5).	Similarly,	the	introduction	of	7-valent	pneumococcal	1262	 conjugate	vaccine	(PCV)	in	April	2009	and	13-valent	PCV	in	April	2011	has	1263	 contributed	to	a	substantial	reduction	in	the	incidence	of	pneumococcal	meningitis	in	1264	 children	<5	years	of	age.	1265	 	1266	
Neisseria	meningitidis	is	the	only	major	cause	of	bacterial	meningitis	outside	the	1267	
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neonatal	period	for	which	routine	immunisation	is	currently	not	available	in	SA.	1268	 According	to	the	GERMS	2016	report,	a	total	of	131	cases	of	laboratory-confirmed	1269	 meningococcal	disease	were	identified	by	the	surveillance	system.	Compared	to	the	1270	 2015	report,	the	incidence	of	meningococcal	meningitis	was	slightly	lower	(0.23	vs	1271	 0.28	cases	per	100	000	population)	(6).		1272	 	1273	 Even	with	the	noted	change	in	epidemiology	of	meningitis	following	introduction	of	1274	 vaccines,	most	children	are	admitted	for	intravenous	antibiotics	while	awaiting	1275	 laboratory	confirmation	for	bacterial	meningitis.	Traditional	laboratory	methods	include	1276	 Gram	stain	and	culture	of	cerebrospinal	fluid	(CSF).	These	have	long	turnaround	times	1277	 and	usually	show	negative	results	especially	in	children	who	receive	antibiotics	prior	to	1278	 CSF	sampling	(4,	7).	In	a	previous	study,	antibiotic	treatment	was	retrospectively	judged	1279	 to	be	unjustified	in	over	80%	of	children	treated	for	longer	than	two	days	(8).	1280	 Inappropriate	use	of	antibiotics	may	lead	to	future	antibiotics	resistance;	it	may	also	1281	 cause	adverse	antibiotic	effects	(9,	10).	1282	 	1283	 Rapid	diagnosis	is	essential	to	confirm	the	cause	of	meningitis	and	institute	appropriate	1284	 timeous	treatment.	Modern	molecular	methods	that	are	based	on	detection	of	nucleic	1285	 acid	sequences	can	provide	rapid	identification	of	both	viral	and	bacterial	pathogens.	1286	 Real	time	Polymerase	Chain	Reaction	(PCR)	can	detect	responsible	pathogens	1287	 independent	of	culture	even	after	antibiotics	have	been	commenced.	Currently	1288	 PCR	is	not	standard	of	care	at	RCWMH	as	well	as	at	most	public	hospitals	in	1289	 South	Africa.	1290	 	1291	 Our	study	aimed	to	describe	the	clinical	features	and	outcomes	of	patients	who	had	1292	
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confirmed	viral	meningitis	on	PCR	testing.	Secondarily	the	study	compared	the	clinical	1293	 features	and	laboratory	findings	in	children	with	confirmed	viral	meningitis	with	1294	 children	with	confirmed	bacterial	meningitis	and	children	in	whom	the	aetiology	of	1295	 meningitis	could	not	be	determined.	1296	 	1297	
Materials	and	methods	1298	
	1299	 Our	 methods	 have	 been	 previously	 published	 (11).	 Briefly,	 residual	 CSF	 samples	1300	 received	by	 the	microbiology	 laboratory	 from	 the	emergency	department	of	 the	Red	1301	 Cross	War	Memorial	Children’s	Hospital	(RCWMCH)	in	Cape	Town,	South	Africa,	were	1302	 prospectively	collected	between	1	November	2012	and	30	October	2013.	The	National	1303	 Health	Laboratory	Services	 (NHLS)	database	was	used	 to	 identify	all	 specimens	with	1304	 abnormal	white	cell	counts	(defined	as	presence	of	any	polymorphs	or	more	than	five	1305	 lymphocytes	in	CSF).	All	children	older	than	60	days	of	age	with	abnormal	CSF	findings	1306	 were	eligible	for	inclusion	if	they	had	sufficient	residual	CSF	for	analysis	(if	they	had	at	1307	 least	1	ml	of	residual	CSF).	Children	with	head	injury	or	existing	skull	defects	(e.g.	base	1308	 of	skull	fracture	or	ventricular-peritoneal	shunt	in	situ)	were	excluded.		1309	 	1310	 A	retrospective	review	of	folders	was	conducted	on	all	subjects	who	met	the	inclusion	1311	 criteria.	Data	including	history	of	clinical	presentation,	prior	exposure	to	antibiotics	and	1312	 indication	for	lumbar	puncture	(LP)	were	sourced	from	the	patient’s	record.	1313	 Examination	findings	at	presentation	prior	to	sampling	of	CSF	were	obtained	from	1314	 admission	notes.	Results	of	laboratory	investigations	including	CSF	Gram	stain	and	1315	 culture,	blood	culture,	a	full	blood	count	and	C-reactive	protein	were	recorded.	Where	1316	 available,	the	patient’s	HIV	status	was	also	recorded.	The	HIV	status	was	classified	as	1317	
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HIV-infected	if	the	children	had	a	positive	HIV	PCR	if	younger	than	18	months	of	age	1318	 or	had	two	positive	ELISA	tests	if	older.	The	children’s	management	plans,	duration	of	1319	 therapy	as	well	as	discharge	diagnosis	were	recorded.	1320	 	1321	
Laboratory	diagnosis	1322	
	1323	 A	diagnosis	of	confirmed	bacterial	meningitis	was	made	in	the	case	of	either	a	positive	1324	 CSF	Gram	stain	or	culture	or	a	positive	blood	culture	result.	A	validated	in-	house	real-1325	 time	multiplex	PCR	assay	was	used	to	test	for	the	presence	of	the	three	common	1326	 bacterial	pathogens	namely,	Neisseria	meningitidis	(ctrA	gene),	Haemophilus	influenzae	1327	 (hpd	gene)	and	Streptococcus	pneumoniae	(lytA	gene)	as	well	as	three	selected	viral	1328	 pathogens:	enterovirus	(5’	UTR),	herpes	simplex	virus	(UL30	gene)	and	mumps	virus	1329	 (Fusion	protein	gene).	PCR	was	carried	out	on	the	Biorad	CFX	96	realtime	instrument	1330	 (11).	1331	 	1332	 In	addition,	routine	molecular	diagnostic	testing	was	carried	out	for	Mycobacterium	1333	 	tuberculosis	complex	(GeneXpert)	on	CSF	and/or	sputum	if	tuberculous	meningitis	1334	 (TBM)	was	suspected.	Viral	and	bacterial	PCRs	were	done	on	batched	specimen	samples	1335	 long	after	the	children	had	been	discharged.	1336	 	1337	
Data	analysis	1338	
	1339	 Descriptive	statistical	data	were	generated	for	all	relevant	variables.	Proportions	were	1340	 used	to	depict	frequencies	of	categorical	data	while	means	with	standard	deviation	(SD)	1341	 or	medians	with	interquartile	ranges	(IQR)	were	used	for	all	continuous	data	as	1342	 appropriate.	Comparisons	were	made	between	laboratory	data	of	subjects	with	1343	
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confirmed	viral	and	bacterial	meningitis	as	well	as	between	viral	and	unconfirmed	1344	 meningitis	using	a	Mann-Whitney	test.	A	two-tailed	p<0.05	was	used	as	the	cut-off	point	1345	 for	significance	at	each	instance.	1346	 	1347	 All	statistical	computations	were	done	on	STATA	software	version	13	(STATA	1348	 Corporation,	College	Station,	TX).	1349	 	1350	
Ethics	1351	
	1352	 Approval	for	the	study	was	granted	by	the	Human	Research	Ethics	Committee	of	the	1353	 University	of	Cape	Town	(HREC	REF	223/2015).	1354	
59		
Results	1355	
	1356	
Baseline	characteristics	of	the	study	population	1357	 	1358	 Of	3247	CSF	samples	that	were	collected	over	the	period,	517	(20%)	were	abnormal	of	1359	 which	292/517	(56.5%)	had	enough	residual	CSF	sample	to	be	included	in	the	analysis	1360	 and	286/292	(97.9%)	children	had	folders	available	for	review.	(Table	1).	Blood	cultures	1361	 were	available	for	57	(19.9).	Viral	PCR	detected	86	(30.1%)	cases	(enterovirus	=	84,	1362	 mumps=2)	while	14	(4.9%)	had	confirmed	bacterial	meningitis	by	either	PCR	or	routine	1363	 culture.	1364	 	1365	 Of	the	286	children	with	sufficient	data	to	be	included	in	the	analysis	152	(53.1%)	were	1366	 male.		The	median	age	of	the	participants	was	19	(IQR	6	–	65)	months.	HIV	status	was	1367	 known	in	178	(62.2%)	children	of	whom	10	(3.5%)	were	HIV	infected.	1368	 	1369	 A	total	of	86	(30.1%)	study	subjects	had	received	antibiotics	before	lumbar	puncture	was	1370	 performed.	In	41	(47.7%)	children	only	oral	antibiotic	had	been	received	prior	to	CSF	1371	 sampling.	A	similar	number	had	received	parenteral	antibiotics	only	while	four	(4.6%)	1372	 had	received	both	oral	and	parenteral	antibiotics.	The	commonest	oral	antibiotic	received	1373	 was	amoxycillin	while	almost	all	the	patients	who	received	parenteral	antibiotics	were	1374	 given	ceftriaxone	(Table	1).	1375	 	1376	 	1377	 	1378	 	1379	 	1380	
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Table	1:	Baseline	characteristics	of	the	study	population	
		Baseline	characteristics	 	 N=286		
Age	
	Median	(IQR)	months	 19	(2-65)		 N	(%)	
Gender	 	Female	 134	(46.9)	Male	 152	(53.1)	
HIV	status	 	Unknown	 108	(37.8)	Negative	 168	(58.7)	Positive	 10	(3.5)	
Pre-hospital	antibiotics	 	None	 200	(69.9)	Oral	amoxycillin	 24	(8.4)	Ceftriaxone	 41(14.3)	
Unknown	antibiotic	 21	(7.3)	
	1381	
	Clinical	presentation	1382	
Table	2:	Clinical	presentation	of	participants	by	PCR	diagnostic	confirmation	
	
Clinical	 All(n=286)	 BM(n=14)	 VM(n=86)	 Unconfirmed	
(n=186)	
P1	 P2	 P3	
Fever	 227(79.4)	 13	(92.9)	 77	(89.5)	 137	(73.7)	 1.000	 0.003	 0.196	
Headache	 111(38.8)	 2	(14.3)	 57	(66.3)	 52	(28)	 <0.001	
	
<0.001	 0.360	
Seizures	 57	(19.9)	 2	(14.3)	 4	(4.7)	 51	(27.4)	 0.197	 <0.001		 0.362	
Vomiting	 153(53.5)	 7	(50.0)	 62	(72.1)	 84	(45.2)	 0.122	 <0.001		 0.726	
Diarrhoea	 63	(22.0)	 2	(14.3)	 7	(8.1)	 54	(29)	 0.609	 <0.001		 0.357	
Meningeal		irritation	 23	(8.0)	 5	(35.7)	 14(16.3)	 4	(2.2)	 0.134	 <0.001		 <0.001	
Photophobia	 21	(7.3)	 0	(0.0)	 15	(17.4)	 6	(3.2)	 0.120	 <0.001		 1.000	
Altered	mental	 13	(4.5)	 9	(64.3)	 1	(4.7)	 3	(1.6)	 <0.001		 1.000	 <0.001	
Irritability	 56	(19.6)	 3	(21.4)	 19	(22.1)	 34	(18.3)	 1.000	 0.460	 0.726	
Poor	feeding	 60	(21.0)	 6	(42.9)	 20	(23.3)	 34	(18.3)	 0.185	 0.339	 0.038	
Apnoea	 2	(0.7)	 0	(0.0)	 0	(0).0	 2	(1.1)	 N/C	 1.000	 1.000	
Bulging	fontanelle	 19	(6.6)	 2	(14.3)	 3	(3.5)	 14	(7.5)	 0.143	 0.201	 0.310	
VM=viral	meningitis;	BM=bacterial	meningitis;			
P	values:	P1=	VM	vs	BM,	P2=	VM	vs	unconfirmed,	P3=	BM	vs	unconfirmed,	N/C=not	calculated	
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Table	2	summarises	the	most	common	clinical	manifestations	of	the	study	population.		1383	 It	also	compares	signs	and	symptoms	between	VM	and	BM.	Most	children	presented	1384	 with	fever	in	227	(79.4%)	cases	followed	by	vomiting	153	(53.5%)	and	reported	1385	 headache	in	111	(38.8%).	Seizures	were	reported	in	57	(19.9%)	of	the	children	of	which	1386	 51	(89.5%)	were	generalised	tonic-clonic	seizures;	34	(59.6%)	of	these	were	diagnosed	1387	 with	febrile	seizures.	Only	32	(11.2%)	children	had	signs	of	meningeal	irritation.	Apnoea	1388	 was	documented	in	two	(0.7%)	children,	both	younger	than	three	months	of	age.			1389	 	1390	 	1391	
Diagnosis	1392	
	1393	 The	diagnosis	was	made	by	the	attending	clinicians	based	on	CSF	cell	counts,	biochemical	1394	 analysis	and	routine	culture	in	addition	to	clinical	presentation.	Discharge	diagnosis	of	VM	1395	 was	made	in	96	(33.6%)	of	the	children	while	94	(32.8%)	children	had	a	diagnosis	of	BM.	1396	 In	the	remaining	96	(33.6%)	children	the	diagnosis	of	meningitis	was	excluded	by	the	1397	 attending	clinician.	1398	 	1399	 The	cause	of	meningitis	was	confirmed	by	PCR	in	100	(35.0%)	of	the	patients;	14	1400	 (14.0%)	were	confirmed	to	have	BM	while	86	(86.0%)	had	confirmed	VM.	Routine	CSF	1401	 or	blood	culture	were	positive	in	7	(50%)	of	the	14	confirmed	cases	of	BM.		Three	of	the	1402	 culture	confirmed	cases	(one	on	blood	culture	alone	and	two	on	CSF	culture)	were	due	1403	 to	S.	pneumoniae,	with	one	each	due	to	N.	meningitidis	and	H.	influenzae.	The	other	two	1404	 cases	had	TBM	(Figure	1).	Of	86	patients	who	had	had	antibiotics	before	LP	was	done,	1405	 only	one	had	a	positive	culture	on	CSF.		1406	 	1407	 It	took	an	average	time	of	9.2	(SD	±4.7)	hours	for	CSF	to	show	bacterial	growth	while	1408	
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blood	cultures	flagged	positive	in	17.4	(SD	±6.0)	hours.	The	two	CSF	specimens	positive	1409	 for	M.	tuberculosis	took	34	and	18	days	respectively	to	show	growth.	One	organism	was	1410	 cultured	in	the	CSF	in	1	of	the	86	children	who	received	prior	antibiotics.	PCR	detected	1411	 an	additional	7	(50%)	children	with	BM	as	shown	in	figure	1.		1412	 	1413	 A	total	of	100	(35.0%)	children	had	a	confirmed	diagnosis	of	meningitis	on	PCR.	Fifty-	1414	 one	(51.0%)	had	been	managed	as	BM	based	on	clinical	features,	routine	microscopy	1415	 and	culture,	42	(42.0%)	were	managed	as	VM	and	seven	(7.0%)	were	treated	for	a	1416	 non-meningitis	diagnosis	(Table	3).	Forty	(46.5%)	of	the	children	treated	for	BM	were	1417	 later	confirmed	to	have	VM	on	PCR.	The	use	of	clinical	evidence	and	routine	1418	 laboratory	detected	VM	with	a	sensitivity	of	48%	(95%	CI	37-	59%)	and	a	specificity	1419	 of	93%	(95%	CI	66-100%)	compared	to	PCR.	1420	 	1421	
Table	3.	Clinical	diagnosis	of	confirmed	meningitis	(N=100)	
Clinical	diagnosis#	 	 Bacterial	
(n=14)	
Viral	(n=86)	 Total		 	 n	(%)	 n	(%)	 	Viral	Meningitis	 	 1	(7.1)	 41	(46.7)	 42	Bacterial	Meningitis	 	 11	(78.6)	 40	(46.5)	 51	Non-meningitis	 	 2	(14.3)	 5	(5.8)	 7	#Included	use	of	routine	CSF	cell	count,	chemistry,	microscopy	and	culture	
	1422	 Real-time	multiplex	PCR	assay	detected	an	additional	seven	cases	of	BM	comprising	five	1423	 cases	of	S.	pneumoniae	and	two	cases	of	N.	meningitidis.	All	positive	CSF	cultures	were	1424	 also	positive	on	PCR.	Negative	CSF	bacterial	culture	results	and	positive	viral	PCR	on	CSF	1425	 confirmed	the	diagnosis	of	VM.	Viral	PCR	was	positive	in	86	(30.1%)	CSF	samples	of	1426	 which	84	(97.7%)	had	enteroviruses,	two	(2.3%)	had	mumps	virus	and	no	cases	of	1427	 herpes	simplex	virus	(HSV)	Figure	1.	1428	 	1429	
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The	cause	of	meningitis	could	not	be	determined	in	186	(65.0%)	samples	as	they	tested	1430	 negative	on	microscopy,	culture	and	on	PCR	for	the	organisms	of	interest.	Apart	from	M.	1431	
tuberculosis	cultured	in	two	CSF	specimens,	no	organism	was	cultured	in	the	CSF	of	the	1432	 86	children	who	received	prior	antibiotics.	Only	four	(4.7%)	of	them	had	positive	PCR	1433	 results	for	BM.	1434	 	1435	 Four	(15.4%)	of	the	26	children	that	underwent	brain	computed	tomography	(CTB)	1436	 scanning	showed	abnormal	findings.	One	CTB	showed	subarachnoid	haemorrhage	with	1437	 acute	hydrocephalus,	the	second	one	showed	bilateral	basal	ganglia	infarcts,	diffuse	1438	 brain	swelling	and	a	right	subdural	hygroma.	The	CSF	PCR	for	the	latter	patient	was	1439	 positive	for	S.	pneumoniae.	The	other	two	abnormal	scans	showed	basal	meningeal	1440	 enhancement	and	communicating	hydrocephalus,	features	in	keeping	with	TBM.	Only	1441	 three	(3.5%)	of	the	86	children	with	confirmed	VM	were	scanned,	all	of	whom	showed	1442	 normal	CT	findings.	1443	 	1444	 Of	the	10	HIV-infected	children,	only	two	(20%)	had	confirmed	BM	while	the	other	eight	1445	 (80%)	had	negative	PCR	results.	No	further	analysis	was	possible	to	compare	HIV	1446	 infected	and	uninfected	children	due	to	the	small	sample	size.	1447	 	1448	
	1449	
Other	laboratory	findings	in	PCR	positive	and	PCR	negative	groups.	1450	
	1451	 The	median	blood	C-reactive	protein	was	46.2	mg/L	(IQR:	19.6	–	173.5	mg/L)	in	1452	 confirmed	BM	and	12.1	mg/L	(IQR:	6.0	-	28.4	mg/L)	in	confirmed	VM;	p=0.009.	CSF	1453	 white	cell	count	was	similar	in	both	groups,	but	a	low	CSF	glucose	(p=0.044)	and	a	1454	
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high	CSF	protein	(p=0.001)	seem	to	be	an	important	finding	in	children	with	BM	1455	 compared	to	VM	or	unclassified	(Table	4).		1456	 		1457	 	1458	
Table	4.	Laboratory	results	by	PCR	confirmed	cause	of	meningitis		
	
(Interquartile	range)]	
	
Laboratory	test	 BM	(n=14)	 VM	(n=86)	 Unconfirmed	(n=186)	 P1	 P2	 P3	
CRP	(mg/L)	 46.2	(19.6-173.5)	 12.1	(6	-	28.4)	 11.6	(2.2-46)	 0.009	 0.869	 0.0167	
WBC	(*10^9)	 17.7	(8.7	-	26.4)	 13.6	(10.4	-	17.1)	 12.9	(10.2	-	19.6)	 0.334	 0.631	 0.6441	
Polymorphs	(/uL)	 38	(1	-	1680)	 43	(10	-	141)	 2	(0	-	11)	 0.960	 <0.001	 0.0044	
Lymphocytes	(/uL)	 110	(9	-	280)	 50.5	(14	-	139)	 8	(5	-	30)	 0.456	 <0.001	 0.0090	
Glucose	(mmol/L)	 3.1	(1.7	-	3.9)	 3.6	(3.3	-	3.9)	 3.6	(3.1	-	4.2)	 0.044	 0.542	 0.0240	
Protein	(g/L)	 0.9	(0.4	-	1.1)	 0.3	(0.2	-	0.4)	 0.3	(0.2	-	0.4)	 0.001	 0.061	 0.0003	
CRP=	C-reactive	protein;	WBC=	White	blood	cell	count;	p<0.05	shown	in	Bold	typeset;	BM=bacterial	meningitis;		VM=viral	meningitis;	P	values:	P1=	VM	vs	BM,	P2=	VM	vs	unconfirmed,	P3=	BM	vs	unconfirmed		1459	 	1460	
Management	and	outcome	of	PCR	confirmed	meningitis	1461	
	1462	 Children	presumed	to	have	VM,	based	on	the	CSF	picture	and	rapid	clinical	improvement,	1463	 were	treated	for	a	median	period	of	1	day	(IQR	1-2	days)	while	those	with	BM	were	1464	 treated	for	a	median	of	5days	(IQR	3-6	days);	p<0.001.	The	usual	treatment	for	presumed	1465	 viral	meningitis	was	supportive	care	and	analgesia.	Two	children	with	TBM	required	1466	 ventricular-peritoneal	shunt	insertion	for	hydrocephalus	as	well	as	a	prolonged	in-patient	1467	 course	of	anti-tuberculous	treatment	(85	and	197	days	respectively).	One	(2%)	child	who	1468	 was	managed	initially	as	VM	was	later	confirmed	to	have	N.	meningitidis	on	PCR.	This	1469	 patient	received	two	doses	of	100mg/kg	of	ceftriaxone	over	two	days	and	did	not	return	1470	 to	the	hospital	after	discharge.	1471	 	1472	 Of	86	children	with	PCR	confirmed	VM,	19	(22.1%)	were	admitted	for	24	hours;	31	1473	
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(36.1%)	were	admitted	for	24-48	hours	and	16	(18.6%)	were	admitted	for	more	than	1474	 48	hours.	Only	20	(23.3%)	children	were	discharged	home	without	antibiotic	treatment.	1475	 Of	those	children	who	had	BM;	only	one	was	admitted	for	24	hours,	the	other	12	1476	 (85.7%)	were	hospitalised	for	more	than	72	hours	and	one	died	within	24	hours	of	1477	 admission.	1478	 	1479	 A	total	of	two	(0.7%)	children	in	the	study	died.	One	had	pneumococcal	meningitis	and	1480	 died	within	24	hours	of	intensive	care	admission.	The	second	child	had	been	diagnosed	1481	 with	presumed	septic	shock	requiring	ICU	admission,	cefotaxime,	ventilation	and	1482	 inotropes.	His	CTB	showed	sub-arachnoid	haemorrhage	with	acute	hydrocephalus	1483	 requiring	drainage	in	theatre.	His	blood	culture,	CSF	Gram	stain,	culture	and	PCR	were	1484	 all	negative.	He	died	after	four	days	of	admission.	1485	 	1486	
Discussion	and	conclusion	1487	
	1488	 Our	study	shows	that	over	30%	of	patients	with	abnormal	CSF	had	confirmed	viral	1489	 meningitis	on	real-time	multiplex	PCR	testing	while	bacterial	meningitis	was	confirmed	1490	 in	only	5%.	Viral	meningitis	accounted	for	85%	of	all	confirmed	meningitis	cases	where	1491	 aetiology	was	found.	Most	of	the	cases	(98%)	were	due	to	enteroviruses	with	a	small	1492	 proportion	due	to	mumps	virus.	This	finding	is	in	keeping	with	the	reported	prevalence	1493	 of	meningitis	which	indicates	that	viral	infections	are	the	commonest	causes	of	1494	 meningitis.	The	fewer	cases	of	BM	are	attributed	to	the	widespread	use	of	vaccines	1495	 targeting	common	bacterial	causes	of	meningitis	in	children.	(12-14).	1496	 	1497	 In	this	study	clinical	signs	of	bacterial	and	viral	meningitis	overlapped	significantly,	and	1498	
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clinicians	had	difficulty	in	distinguishing	between	the	two.	Comparing	children	with	VM	1499	 with	those	who	had	BM,	headache	and	altered	mental	state	gave	statistical	different	1500	 results	(p<0.05).	Fever,	headache,	seizures,	vomiting,	diarrhoea,	meningeal	irritation	1501	 and	photophobia	also	gave	significant	results	between	VM	and	the	unclassified	group.	1502	 Between	and	the	unclassified	group,	only	meningeal	irritation,	decreased	mental	state	1503	 and	poor	feeding	were	suggestive	of	BM	as	shown	in	table	2.		1504	 	1505	 Additional	laboratory	support	is	thus	required	to	determine	aetiology.		A	large	1506	 proportion	of	children	later	confirmed	to	have	VM	(46%)	were	admitted	and	treated	1507	 with	antibiotics	as	for	BM.	1508	 	1509	 According	to	de	Crom	et	al.	the	acute	onset	of	fever,	headache,	nausea,	vomiting,	stiff	1510	 neck,	and	photophobia	are	common	presenting	symptoms	of	VM	(15).	Because	of	the	1511	 retrospective	nature	of	our	study,	we	could	not	compare	patients’	clinical	presentations	1512	 in	detail.	In	another	study	the	frequency	of	seizures	was	found	to	be	higher	in	BM	and	1513	 encephalitis	than	VM	(16),	in	our	study	there	was	no	difference.	1514	 	1515	 CSF	Gram	stain	and	culture	with	clinical	input	has	poor	sensitivity	in	detecting	1516	 meningitis.	Our	study	showed	no	detectable	differences	in	the	CSF	cell	counts	of	VM	1517	 and	BM.	Although	predominance	of	polymorphs	is	regarded	as	a	feature	of	BM,	there	is	1518	 good	evidence	that	early	VM	can	have	polymorph	predominance	(4,	6).	In	a	study	1519	 conducted	by	Potter	et	al,	children	with	purulent	CSF	and	polymorph	predominance	1520	 turned	out	to	have	VM	and	recovered	quickly	(17).	1521	 	1522	 We	found	statistically	significant	differences	in	CSF	chemistry	between	VM	and	BM	1523	
67		
cases	(low	glucose	and	high	protein	in	BM)	as	previously	described(18).While	1524	 chemistry	can	be	used	as	a	guide	for	differentiating	VM	from	BM,	it	is	not	diagnostic	for	1525	 either	condition	on	its	own.	1526	 	1527	 In	the	absence	of	laboratory	viral	confirmation,	VM	diagnosis	is	made	by	excluding	BM	1528	 in	the	absence	of	bacteria	on	CSF	Gram	stain	and	culture.	After	LP,	children	with	CSF	1529	 pleocytosis	are	routinely	admitted	and	put	on	intravenous	antibiotics	for	48	hours	1530	 pending	the	outcomes	of	bacterial	culture.	The	ones	who	received	antibiotics	prior	to	LP	1531	 often	end	up	with	a	full	course	of	BM	treatment	as	negative	culture	becomes	unreliable	1532	 in	excluding	BM.		1533	 	1534	 Our	study	found	that	a	large	proportion	of	children	(47%)	with	confirmed	VM	were	1535	 diagnosed	and	managed	as	BM.	This	misdiagnosis	resulted	in	prolonged	hospital	stay	1536	 and	inappropriate	usage	of	antibiotics.	This	imposes	an	undue	financial	burden	on	1537	 healthcare	services	as	well	as	an	increase	the	risk	of	resistance	to	antibiotics.	Gram	stain	1538	 and	bacterial	culture	also	missed	cases	of	PCR	confirmed	BM	even	in	children	without	1539	 exposure	to	antibiotics	prior	to	CSF	collection.	1540	 	1541	 CRP	has	been	used	as	an	additional	test	and	has	been	shown	to	have	a	high	sensitivity	1542	 for	bacterial	infection	depending	on	when	the	sample	is	taken.	Its	specificity	is	high	with	1543	 values	above	40mg/L	(19).	In	our	study,	there	were	significantly	higher	average	levels	1544	 of	CRP	in	BM	compared	to	VM.	The	small	sample	of	BM	cases	in	our	study	did	not	allow	1545	 us	to	establish	a	diagnostic	cut-off	point	for	BM	in	our	population.	All	other	laboratory	1546	 findings,	including	WCC	did	not	differ	significantly	between	confirmed	BM	and	VM.	1547	 	1548	
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Blood	culture	results	have	been	used	to	aid	with	the	diagnosis	of	BM.	Only	57	(20%)	of	1549	 our	children	had	blood	cultures	taken.	All	children	in	our	study	with	positive	blood	1550	 cultures	showed	the	same	bacteria	in	the	CSF.	PCR	detected	VM	meningitis	cases	that	1551	 should	otherwise	not	need	admission	and	antibiotics.	It	also	picked	up	an	additional	four	1552	 cases	of	BM	which	were	missed	on	CSF	Gram	stain	and	culture.	This	indicates	that	PCR	1553	 sensitivity	is	superior	to	that	of	CSF-	culture	isolation	for	confirming	meningitis	due	to	1554	 both	bacteria	and	viruses	(19,	20).		1555	 	1556	 The	main	risk	factor	for	false	negative	culture	is	prior	exposure	to	antibiotic	(21,	22).	1557	 PCR	can	detect	organisms	in	antibiotic-exposed	patients	who	would	have	negative	1558	 culture	hence	decreasing	patient	hospital	length	of	stay	and	reduce	inappropriate	use	of	1559	 antibiotics	(23-	26).		1560	 	1561	 There	is	an	urgent	need	to	consider	routine	use	of	PCR	in	the	diagnosis	of	meningitis	in	1562	 children.		Real-time	multiplex	PCR	offers	value	in	accurately	detecting	common	viral	and	1563	 bacterial	pathogens	thus	allowing	for	appropriate	patient	management.	Even	where	1564	 limited	resources	do	not	allow	for	two	assays	our	study	suggests	that	viral	PCR	alone	1565	 would	identify	a	large	number	of	children	with	VM	who	do	not	require	antibiotics.	PCR	1566	 testing,	however,	should	be	done	in	addition	to	culture,	not	as	a	replacement.	Otherwise	1567	 one	risks	losing	the	organisms	not	included	in	the	PCR	assay,	as	well	as	the	ability	to	do	1568	 susceptibility	testing	and	strain	typing.	An	economic	evaluation	would	be	useful	in	making	1569	 this	decision.	The	current	cost	of	the	PCR	is	R586	(±USD	40)	-	relative	to	a	CSF	cell	count,	1570	 microscopy	and	culture	which	cost	R114.83.		1571	
	1572	 Our	study	highlights	the	need	for	using	currently	available	methods	for	the	diagnosis	of	1573	
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viral	meningitis	children	with	emphasis	on	excluding	or	confirming	viral	meningitis	to	1574	 reduce	the	need	for	unnecessary	admission	and	treatment	with	antibiotics.	1575	 	1576	 Our	study	was	limited	by	the	use	of	retrospective	data.	As	a	result,	key	clinical	data	was	1577	 missing	in	some	instances	and	detailed	analysis	could	not	be	carried	out.	As	the	PCR	1578	 assays	used	only	tested	for	preselected	pathogens,	a	negative	test	does	not	exclude	1579	 meningitis	due	to	other	pathogens.	This	may	account	for	the	large	proportion	of	1580	 unconfirmed	meningitis.		1581	
	1582	 A	prospective	study	is	needed	to	evaluate	the	narrow	economic	as	well	as	the	broader	1583	 societal	cost	effectiveness	of	PCR	testing	in	managing	children	with	suspected	viral	1584	 meningitis.	Such	a	study	should	be	sufficiently	powered	to	assess	the	cost	of	using	PCR	to	1585	 diagnose	meningitis	compared	to	traditional	methods	and	the	resultant	impact	on	1586	 paediatric	admissions	for	meningitis,	hospital	length	of	stay	and	antibiotic	usage.	1587	 	1588	 In	conclusion,	this	study	highlights	the	potential	of	PCR	in	improving	diagnostic	accuracy	1589	 and	reducing	the	cost	of	managing	children	with	suspected	viral	meningitis.	1590	 	1591	
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Figure 1: Comparing cerebrospinal fluid(CSF) micropscopy and culture to CSF polymerase chain reaction 
NB. An extra case of S. pneumoniae was confirmed on blood culture only
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